[go: up one dir, main page]

WO1990010080A1 - Production of nucleoside - Google Patents

Production of nucleoside Download PDF

Info

Publication number
WO1990010080A1
WO1990010080A1 PCT/JP1990/000240 JP9000240W WO9010080A1 WO 1990010080 A1 WO1990010080 A1 WO 1990010080A1 JP 9000240 W JP9000240 W JP 9000240W WO 9010080 A1 WO9010080 A1 WO 9010080A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleoside phosphorylase
microorganism
nucleoside
enzyme
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1990/000240
Other languages
French (fr)
Japanese (ja)
Inventor
Hiroshi Yamauchi
Hideki Utsugi
Yuichiro Midorikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26389109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1990010080(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Priority to KR1019900702343A priority Critical patent/KR970010134B1/en
Priority to EP90903422A priority patent/EP0411158B1/en
Priority to CA002028119A priority patent/CA2028119C/en
Priority to DE69027154T priority patent/DE69027154T2/en
Publication of WO1990010080A1 publication Critical patent/WO1990010080A1/en
Anticipated expiration legal-status Critical
Priority to US08/319,574 priority patent/US5506122A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus

Definitions

  • the present invention relates to a method for producing a nucleoside using an enzyme preparation containing a nucleoside phosphorylase derived from a thermophilic bacterium belonging to the genus Bacillus.
  • Methods for producing nucleosides by enzymatically reacting a sugar residue donor such as nucleoside, ribose-1-phosphate or the like with a base donor include, for example, methods for producing various nucleosides.
  • the synthesis of a compound is brought about by the fact that the equilibrium between the production reaction and the decomposition reaction is inclined toward the production reaction.Therefore, in order to increase the yield and yield of the compound, the production reaction must be promoted and the decomposition It is essential to suppress the reaction, and this principle is no exception in the production of enzymatic compounds.
  • the reaction temperature is increased, the reaction rate is increased, the reaction is completed in a short time, and the solubility of the substrate is also increased. ing.
  • nucleoside phosphorylase When producing nucleosides using nucleoside phosphorylase, two factors must be considered in order to accelerate the nucleoside production reaction: the ability of the enzyme itself to be used as a catalyst and the reaction conditions. No. The selection of reaction conditions is only a supplementary step to bring out the ability of the enzyme to be used, and a drastic method for promoting the production reaction and increasing the yield of the target compound has excellent ability. This is to use nucleoside phosphorylase.
  • nucleoside phosphorylases used for the production of nucleosides are prepared from microorganisms that can be easily prepared. However, when the ability of the enzyme was examined from the viewpoints of reaction efficiency, specific activity, heat resistance, yield of the target compound, etc., those conventionally used were not always satisfactory.
  • the present inventors screened various microorganisms to find an enzyme having excellent ability to be used for enzymatic production of nucleosides.
  • nucleoside dofoliphorylase has been isolated and purified from Bacillus stearothermophilus, a thermophilic bacterium belonging to the genus Bacillus, and its enzymatic properties have been studied and reported (J. Biol. Chem .. 244, 3891). ⁇ 3697 (1969), Agric. Biol. Chera., 53, 2205-2210 (August 23, 1989),
  • thermostable nucleoside phosphorylase having high specific activity and high heat resistance, and having high nucleoside phosphorylase activity per unit weight of bacterial cells, as described above.
  • 1 These microorganisms have high specific activity, heat-resistant nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, and contain nucleosidase.
  • a base donor, a sugar residue donor, and a phosphate donor are reacted using a nucleoside phosphorylase preparation, and the base moiety of the base donor and the sugar moiety of the sugar residue donor are reacted.
  • An N-glycosidic bond is formed between
  • a nucleoside phosphorylase-containing enzyme preparation is selected from the group consisting of one of thermophilic bacteria belonging to the genus Bacillus which has a high nucleoside phosphorylase activity per unit weight of the bacterial cell.
  • the present invention relates to a method for producing a nucleoside, which is characterized by using a substance derived from the species of two or more microorganisms.
  • nucleoside includes naturally occurring nucleosides such as peridine, thymidine, cytidine, adenosine, and guanosine, as well as various nucleoside analogs. This indicates the range to perform.
  • the present invention also relates to the above enzyme preparation itself, a novel microorganism used for preparing the enzyme preparation, and a novel nucleoside phosphorylase prepared from the microorganism and which can be used for production of nucleoside. Things.
  • FIG. 1 shows the optimum pH and stable pH range of the purine nucleoside phosphorylase of the present invention.
  • FIG. 2 shows the optimum temperature and stable temperature range of the purine nucleoside phosphorylase of the present invention.
  • FIG. 3 shows the optimum pH and the stable pH range of the pyrimidine nucleoside phosphorylase of the present invention.
  • FIG. 4 shows the optimum temperature and the optimum temperature of the pyrimidine nucleoside phosphorylase of the present invention.
  • Fig. 5 shows the stable temperature range.
  • —2 and Brevibacterium acetylicum AT 6-7 were used as enzyme sources to produce 11-S-D-ribofuranosyl 1,2,4-triazole-3-carboxamide (rivapyrin). It is a comparison of rivapirin production rates at different reaction times.
  • the “enzyme preparation containing nucleoside phosphorylase” (hereinafter referred to as “enzyme preparation”) of the present invention includes: The term refers to those containing at least one of nucleoside phosphorylase or pyrimidine nucleoside phosphorylase, but preferably both nucleoside phosphorylases.
  • degree of purification of the enzyme means the ratio of the amount of the enzyme protein to the total amount of the protein.
  • the enzyme preparation of the present invention includes thermophiles belonging to the genus Bacillus, specifically, Bacillus It can be prepared from microorganisms belonging to a group of microorganisms having high nucleoside phosphorylase activity per unit weight of cells (hereinafter referred to as microorganisms of the present invention) among microorganisms belonging to moderately thermophilic bacteria such as stearotherniophilus).
  • Nucleoside phosphorylase for selecting microorganisms for the activity, for example, the following values are a rough guide.
  • Those satisfying one of these two conditions can be used as a preparation source of an enzyme preparation used in the present invention, and those satisfying both of the above two conditions at the same time It is suitable as a preparation source for products.
  • suitable microorganisms satisfying such conditions include Bacillus stearothera (Philas TH62, P-21 and P-23) (both in the hamasa soy sauce premises) (Soil isolates isolated from soil).
  • Bacillus stearothera Philas TH62, P-21 and P-23 (both in the hamasa soy sauce premises) (Soil isolates isolated from soil).
  • the bacteriological properties of the TH6-2 strain which is the most representative strain of the strain group, are shown below.
  • Negative starch, glycerol, sucrose, raffinose
  • Glucose did not grow in the presence of 0.5% or more.
  • the isolated bacteria were Bacillus ⁇ stearoser. It was found to belong to the morphophilus, and was named Bacillus ⁇ stearoser morphiras TH 6-2. P-21 and P123 also showed the same mycological properties.
  • TH-6-2 has been deposited with the Institute of Microbial Industry and Technology of the National Institute of Advanced Industrial Science and Technology under the Budapest Treaty. No. 2 758 is given. This international deposit was transferred on February 16, 1990 from No. 10526, deposited on the depository organization in Japan on February 4, 1989.
  • TH 6-2, P-21, and P-23 all belong to the Bacillus ⁇ stearoser philus, but have a very high nucleoside phosphorylase activity per unit weight of bacterial cells and have a high level of nucleosidase activity. It is clearly distinguished from known microorganisms in that it does not substantially contain it. For example, using a known microorganism belonging to Bacillus stearothermophilus stored in the American ⁇ Type ⁇ Culture 'Collection (ATCC) and the above isolated bacteria, cell units can be used. Table 1 shows the results of a comparative study of the activity of bilimidine nucleoside phosphorylase and purine nucleoside phosphorylase per weight.
  • nucleoside phosphorylase activity per unit cell weight of D-H6-2, P-21 and P-23 is higher than that of the previously known strains. It can be seen that the activity is slightly less than 2-fold for nucleoside phosphorylase activity and slightly more than 6-fold for pyrimidine nucleoside phosphorylase activity.
  • the above isolated bacteria have a purine nucleoside phosphorylase activity and a pyrimidine nucleoside phosphorylase activity per unit cell weight of 13 to 15 U / g wet cells and 20 to 50 U / g, respectively. The value of 22 U / wet cells was shown. Table 1
  • this isolated bacterium sufficiently satisfies the selection criteria for nucleoside phosphorylase activity described above, and is useful as a preparation source for an enzyme preparation used for producing nucleosides.
  • the cells of the microorganism were prepared in the same manner as in Example 1 described below, and the measurement of the activity of prinnucleoside phosphophorylase and pyrimidine nucleoside phosphorylase was performed using the titer described below. The measurement was performed according to the method described in In addition, livapirine is prepared by using a substrate solution (pH containing 40 mM 1,2,4-triazole-3-carboxamide, 60 mM resin, 40 mM dihydrogen phosphate).
  • the suspension was prepared by adding 1 Oml (containing 200 nig as wet cells) of a cell suspension in which the cell weight was adjusted to 1 Oml, and stirring at 50 for 24 hours. After the above reaction, the reaction solution was centrifuged, and the supernatant was diluted 50- to 100-fold, and this was subjected to the HPLC method (column: YMC A
  • the generation rate was determined by the following equation. Concentration of generated ribavirin (M)
  • the enzyme preparation of the present invention is obtained by culturing a microorganism belonging to the microorganism group of the present invention and culturing the cells. Can be prepared by appropriately processing into a use form according to the purpose of use.
  • a culture medium for culturing microorganisms contains an appropriate amount of a carbon source and a nitrogen source which can be assimilated by these microorganisms, and if necessary, a metal salt, a trace growth promoting substance, an antifoaming agent, etc. The added one is used.
  • medium components include sugars (glucose, saccharose, etc.), natural carbohydrates (molasses, molasses, starch, wheat, bran, rice, etc.), alcohols, fatty acids, hydrocarbons
  • Nitrogen sources include meat extract, yeast extract, soy hydrolyzate, casamino acids, various amino acids, urea, etc.
  • Inorganic salts include zinc, iron, magnesium, sodium, calcium, calcium
  • trace growth-promoting substances such as phosphates, hydrochlorides, and sulfates of metals such as chromium, include vitamin 8 2, vitamin B 2 , amino, pentatothenic acid, and biotin.
  • Culture may be performed by a conventional liquid culture method (eg, supernatant culture, aeration-agitation culture, stationary culture, or continuous culture).
  • a conventional liquid culture method eg, supernatant culture, aeration-agitation culture, stationary culture, or continuous culture.
  • Culture conditions vary depending on the microorganism and the type of medium, and cannot be specified. Usually, the pH at the start of the culture is adjusted to 6.5 to 9.0, and the temperature is adjusted to about 35 to 65 ° C until the desired enzyme activity is sufficiently obtained. Incubate for about 50 hours.
  • the embodiment of the enzyme preparation prepared using the culture solution containing the viable cells thus obtained is not particularly limited.
  • culture the culture of the microorganism itself, culture Normal separation means (centrifugation, sediment -1 1-
  • processed cells of live cells are mechanical destruction of live cells (using a waling ⁇ blender, French ⁇ press, homogenizer, mortar, etc.), freeze-thawing, drying (freezing) Drying, air drying, acetate drying, etc.), autolysis (using a solvent such as toluene or ethyl acetate), enzyme treatment (using cell wall lysing enzymes such as lysozyme), ultrasonic treatment, osmotic pressure treatment Destruction of viable cells obtained by treatment in accordance with general treatment methods such as chemical methods, chemical treatment (using salt solution, acidic solution, alkaline solution, surfactant, chelating agent, etc.) Denature the cell wall or Z of living cells and the cell membrane, or extract a fraction with enzymatic activity, and if necessary, extract the extract with enzymatic activity into a common enzyme.
  • general treatment methods such as chemical methods, chemical treatment (using salt solution, acidic solution, alkaline solution, surfactant, chelating agent, etc.)
  • Such cultures, viable cells and treated cells may be used in the free state without immobilization treatment, and may be immobilized by ordinary methods such as inclusive method, cross-linking method and adsorption method. It may be used as an immobilized material.
  • the nucleoside phosphorylase obtained by extraction and purification from Bacillus stearothermophilus TH6-2 belonging to the microorganism group of the present invention has the following enzymatic properties.
  • the purine nucleoside phosphorylase of the present invention catalyzes the above-mentioned phosphorylation reaction. For this reason, it belongs to E. C. 2.4.2, 1 of the International Enzyme Classification.
  • Table 3 shows the results of phosphorylation of various purine nucleotides as substrates.
  • the purine nucleoside phosphorylase of the present invention is specific for inosine, 2'-deoxyinosine, guanosine and 2'-deoxyguanosine within the range tested.
  • the optimal pH is pH 7-8, and the stable pH range is pH 5-9 (see Figure 1).
  • the optimum temperature is 60-80 ° C: the stable temperature range is up to 60 (see Fig. 2).
  • the molecular weight is about 45,000 as measured by SDS-Polyacrylamide gel electrophoresis. '
  • the specific activity is more than 400 (U / mg) at 80% enzyme purification and 450 (U / mg) at 90% enzyme purification.
  • the pyrimidine nucleoside phosphorylase of the present invention catalyzes the above-mentioned phosphorylation reaction. For this reason, it belongs to the International Enzyme Classification EC 2.4.2.2. (2) Substrate specificity
  • Table 4 shows the results of phosphorylation of various pyrimidine nucleotides as substrates.
  • the pyrimidine nucleoside phosphorylase of the present invention is specific to peridine, 2'-dexoxylysine, ribofuranosylthymine, and thymidine within the range tested.
  • the optimal pH is pH 7-9, and the stable pH range is pH 5-9 (see Figure 3).
  • the optimum temperature is 60 to 70, and the stable temperature range is up to 60 ° C (see Fig. 4).
  • the molecular weight measured by SDS-polyacrylamide electrophoresis is about 31,000.
  • the specific activity is more than 250 (U / ing) at 80% enzyme purification and 297 (U / mg) at 90% enzyme purification.
  • Prin nucleoside phosphorylase activity-Substrate solution pH 8.0 aqueous solution containing 20 mM inosine and 0.1 M potassium dihydrogen phosphate
  • enzyme solution 1 g as purified enzyme
  • 50 mM ⁇ after buffer (p H 6. 0) 50 mM ⁇ after buffer (p H 6. 0)
  • hydrochloric acid 20 £ added and reacted for 10 minutes at 50 e C, reaction by adding hydrochloric acid so that such a 0. iN at a final concentration Stop and cool at 0 for 10 minutes.
  • reaction solution was centrifuged, and the obtained supernatant was subjected to an HPLC method (column: YMC A- 312 (manufactured by Yamamura Chemical Laboratory), eluent: 20 mM toluene containing 5.0% of acetonitrile). Quantify the amount of hypoxanthine produced in squirrel-HCl buffer (pH 7.5), detection: 260 nm). In one minute One two
  • the procedure is the same as the above-described method for measuring the phosphoryl phosphorylase activity except that peridine is used instead of inosine in the substrate solution and peracyl is quantified by the HPLC method.
  • One unit is the amount of enzyme that produces 1 mol of peracil per minute.
  • Dissolve nucleosides (20 mM inosine or peridine) and 0.1 M potassium dihydrogen phosphate, and adjust the pH to 4 with an aqueous solution of dilute hydrochloric acid or dilute sodium hydroxide.
  • the procedure is performed in the same manner as in the measurement of the activity of purine nucleotide phosphorylase, except that the substrate solution adjusted to ⁇ 10 is used.
  • the reaction is performed in the same manner as in the measurement of the activity of purine nucleoside phosphorylase or pyrimidine nucleoside phosphorylase, except that the reaction is carried out at each temperature of 30 to 80.
  • the measurement is performed in the same manner as in the method for measuring the activity of purine nucleoside phosphorylase or pyrimidine nucleoside phosphorylase.
  • the characteristics of the enzymes obtained from the microorganisms in the microorganism group of the present invention described above are that they have an optimum temperature and a stable temperature range to a relatively high temperature, and have a very high specific activity. Therefore, if a preparation containing an enzyme having such characteristics is used for the production of a nucleotide, the amount of the enzyme preparation used in the reaction can be reduced, and the nucleotide amount can be reduced with a small amount of the enzyme. Can be manufactured with good yield. Furthermore, since the reaction can be performed at a relatively high temperature (45 or more), contamination by various microorganisms can be prevented.
  • the production of a nucleoside using the above enzyme preparation is carried out in a reaction vessel in the form of a base donor, a sugar residue donor and a sugar residue donor described below.
  • the reaction can be carried out by contacting a phosphoric acid donor with an enzyme preparation.
  • the base donor used in the method of the present invention supplies a base to the reaction system.
  • the base donor to be used may be selected according to the target nucleotide, and the N-glycosidic bond between the sugar moiety of the sugar residue donor and the N-glycosidic bond is formed by the action of nucleoside phosphorylase.
  • Examples of the heterocyclic base to be formed or a derivative thereof can be given.
  • Specific examples of the heterocyclic base include, for example, purine and its derivatives, pyrimidine and its derivatives, triazole and its derivatives, imidazole and its derivatives, azapurine and its derivatives, azapurine and its derivatives, And azapyrimidine and its derivatives or pyridine and its derivatives.
  • the base donor may be not only the heterocyclic base itself, but also a nucleotide or a nucleotide having the heterocyclic base.
  • a substituent for example, an amino group, a substituted amino group, a hydroxyl group, an oxo group, a mercapto group
  • a substituent is provided at one or more positions of the 1, 2, 6, or 8 positions of the prim base.
  • Derivatives having a group, an acyl group, an alkyl group, a substituted alkyl group, an alkoxyl group, a halogeno atom for example, adenine, guanine, hypoxanthine, xanthine, 6-mercaptoprin, 6-thioguanine, ⁇ ⁇ -alkyl Or acyladenine, 2-alkoxyadenine, 2-thioadenine, 2,6-diaminoprin, etc .; at one or more of the 2-, 4- or 5-positions of pyrimidine, the same as above Pyrimidine derivatives having a substituent, for example, cytosine, peracyl, thymine, 5-no, logenouracil (eg, 5-fluorouracil, 5-hydroxyuracil, etc.), 5-halogenosit Shin (5 - Furuoroshi Toma, etc.), 5 - Application Benefits halogenoalkyl methyl ⁇ La sill (5 - Application Benefits
  • 8-azaazadenine, 7-aza-8-azahipoxa Derivatives such as azapurinol (aroprinol); azapyrimidine derivatives such as 5-azathymine, 5-azacitosine, 6-azaduracil; and azapyrimidine derivatives such as 3-dezaduracil, nicotinic acid, and nicotinic acid amide Examples include pyridin derivatives.
  • the sugar residue donor supplies a sugar residue to the reaction system.
  • the sugar residue donor may be selected according to the target nucleotide, and an N-glycosidic bond is formed with the base moiety of the base donor by the action of nucleoside phosphorylase.
  • a ribose compound and a deoxyribose compound can be exemplified.
  • ribose compounds include ribonucleosides such as inosine, guanosine, peridine, ribofuranosylthymine, and ribose-1-phosphate
  • deoxyribose compounds include: 2'-deoxyinosine, 2'-deoxyguanosine, 2'-deoxyperidine, thymidine, 2 ', 3'-dideoxyinosine, 2', 3'-dideoxyguanosine, 2 ', 3' -Doxy nucleosides such as didoxyperidine, 3'-deoxythymidine, and 2-dexoxyribose-1-linoleic acid, and 2,3-dideoxyribose-1-linoleic acid. it can.
  • Ribose compounds such as nosin, cytidine and xanthosine, and deoxyribose compounds such as 2'-deoxyadenosine, 2'-dexoxytidine and 2'-dexoxyxanthosine have the potential to be used.
  • any one capable of dissociating into phosphate ions in the reaction solution may be used.
  • free phosphate or phosphate eg, sodium, potassium
  • a system capable of releasing phosphate ions in the reaction solution such as a combination of various phosphate ester derivatives and phosphatase, or a combination of nucleotide and nucleotidase is used. You can also. 4 Reaction conditions
  • reaction solution a solution prepared by dissolving or suspending a base donor, a sugar residue donor and a phosphate donor in water or a buffer solution is used.
  • the nucleoside corresponding to the base donor is enzymatically produced.
  • the concentrations of the base donor, sugar residue donor and phosphoric acid donor used may be appropriately selected from the range of 0.1 to 500 mM.
  • the reaction usually proceeds efficiently in the range of 35 to 8 CTC, but a reaction temperature of about 40 to 70 is particularly preferred. When the reaction temperature is 35 or less, the reaction speed is slow and the reaction efficiency is low. not good. At a reaction temperature of 80 ° C or more, nucleoside phosphorylase activity may be reduced.
  • the pH of the reaction solution is usually maintained in the range of pH 5 to 10, preferably pH 5 to 9.
  • the pH may be adjusted to a preferable pH range using an acid or alkali.
  • reaction solution and the enzyme composition are separated, and the target nucleoside is subjected to a separation and purification step.
  • the generated nucleoside can be separated and purified by a known method or a method using the same. For example, use of various liquid chromatography such as ion exchange chromatography, adsorption chromatography, distribution chromatography, gel filtration, counter-current distribution, and counter-current extraction. Common separation and purification methods used in the separation and purification of nucleotides, such as methods that utilize differences in solubility such as concentration, cooling, and addition of organic solvents, etc., alone or in combination as appropriate. Just do it.
  • the obtained culture was centrifuged to collect the cells, and after washing, sterilized water was added to prepare a 250-ml cell suspension.
  • a 10 ml aliquot of this bacterial cell suspension was taken, and a substrate solution (pH 6.6) containing 40 mM base donor, 40 mM sugar residue donor and 40 mM dihydrogen phosphate reagent was prepared. 0) 10 ml was added, and the mixture was reacted at 40 to 60 with stirring.
  • the amount of various nucleotides produced was determined by high performance liquid chromatography (column: YMC A-312 (manufactured by Yamamura Chemical Laboratory), eluent: 2.5 to 5% acetonitrile The measurement was carried out using a 2 OmM Tris-HCl buffer containing ril (pH 7.5), detection: absorption at 250 to 260 nm.
  • the nucleoside generation rate was determined by the following equation.
  • Base donors (aloprinol, benzimidazole, 6-mercaptoprin, purine, 6-thioguanine) 20 mM.
  • Sugar residue donors (peridine, 2'-dexoxylysine) 30 mM and The reaction was carried out at 50 ° C for 8 hours in the same manner as in Example 1 using lithium dihydrogenate (30 mM), and the ribofuranosyl compound or 2'-deuterine having various base donors as bases was reacted. An oxyribofuranosyl compound was produced, and the results are shown in Table 6.
  • triazole 40 mM 1,2,4-triazole-3-carboxamide (hereinafter referred to as “triazole”) as a base donor, and 40 mM pyridine and inosine as sugar residue donors , Cytidine, adenosine or guanosine,
  • the nucleoside phosphorylase of the present invention is used for cytidine and adenosine. Since zeotide does not recognize it as a substrate, it is considered that it is used as a substrate after being converted to peridine and inosine by coexisting deaminase, respectively.
  • a substrate solution (pH 6.0) containing 40 mM triazole as a base donor, 60 mM inosine as a sugar residue donor, and 40 mM rhodium dihydrogen phosphate was used. Similarly, the reaction was carried out at each reaction-temperature (40 to 70 ° C) for 24 hours to produce ribavirin. Table 8 shows the results. 5 one
  • the culture obtained by culturing in the same manner as in Example 1 was centrifuged to obtain viable cells.
  • the viable cell 2. was suspended in 0.1 ml of 0.1 M Tris-HCl buffer (pH 7.0), and the light-curable resin (ENT-2000; Kansai Paint II) prepared separately was suspended in Oml.
  • the above cell suspension was added to a resin solution in which 8.0 g of benzoethyl ether as a photopolymerization initiator was added to 8.0 g, mixed well, and then poured onto a transparent film. Then, a light beam of about 360 nm was simultaneously irradiated on the front and back of the film surface for 3 minutes to obtain a photopolymer.
  • a portion containing 0.2 g as a cell mass is taken from the immobilized product, cut into small pieces, and then cut into 40 mM triazole, 40 mM lysine and 60 mM dihydrogen phosphate.
  • the above immobilized product was added to 1 Oml of a substrate solution (pH 6.0) containing a solution, and stirred at 6 ° for 8 hours to produce rivapirin.
  • the production rate of rivapirine was 90% in terms of triazole ratio. Further, this reaction was performed 10 times continuously, but the production rate of ribavirin was maintained at 90%, and a decrease in enzyme activity was observed.
  • Triazole, peridine or inosine, and dihydrogen phosphate rim were added to the culture obtained in the same manner as in Example 1 to a final concentration of 40 mM, respectively. Shaking culture was performed at 0 ° C (when using peridine) or 65 ° C (when using inosine) for an additional 24 hours. After cultivation, the centrifugal supernatant was used to measure the production rate of ribavirin by the HPLC method. As a result, the production rate of ribavirin using lysine was 91.9% in triazole ratio, and When used, the yield was 65, 9%.
  • the cells were inoculated into a large test tube containing 1 Oml of the medium adjusted to 2, and cultured at 50 overnight.
  • the obtained culture was transferred to a 300-ml flask containing 30 ml of a medium having the same composition and the same pH, and cultured at 50 for 8 hours.
  • Approximately 30 g of wet cells were obtained from the thus obtained culture solution by centrifugation, and 1.5% of 0.1% Triton X-100 (manufactured by Shidama) was obtained.
  • the suspension was suspended in 50 mM Tris-HCl buffer (pH 7.2) containing 5 mM EDTA, and 75 mg of lysozyme (manufactured by Sigma) was added, and the mixture was kept at 37 for 1 hour.
  • the lysate was centrifuged at 8,000 rpm to remove cell debris, adjusted to pH 6.0 by adding 2N hydrochloric acid, and heat-treated at 50 for 5 minutes. And centrifuged to obtain a supernatant as a crude enzyme solution.
  • the crude enzyme solution was fractionated by salting out using ammonium sulfate, and the protein precipitate obtained at 40% to 90% saturation was added to a 50 mM acetic acid-sodium acetate buffer (pH 6.0). lysed, overnight dialyzed against large volumes of the same buffer, the resulting inner solution centrifuged t supernatant above acetate buffer to remove the precipitate formed during dialyzed with (hereinafter buffer a and Column) equilibrated in the above)
  • Table 9 shows the amount of protein, the total activity, and the degree of purification of the active fractions in the purification process of both enzymes.
  • the degree of purification was determined by measuring the relative ratio of each band using a densitometer on the electrophoretic pattern obtained by SDS-polyacrylamide gel electrophoresis.
  • ⁇ 3 ⁇ 4white S is 608 Omg. »The amount of protein is 377 Omg ⁇
  • a substrate solution containing 0.4 mM triazole, 0.4 mM lysine and 0.4 mM dihydrogen phosphate was added to each of the cell suspensions (AT 6-7). If the pH is 7. ⁇ or TH6—2, adjust the pH to 6.) Add 10 ml and react with stirring at 45 ° C or 65 ° C in a closed system. The sample was sampled and the production rate of rivapirine was measured by the aforementioned HPLC method.
  • Fig. 5 shows the results. As is evident from Fig. 5, when the enzyme preparation prepared from the microorganism of the present invention was used, the target compound was produced in a shorter time than AT 6-7, which was conventionally a very excellent source of enzyme preparation. It was clarified that the enzyme preparation could be used in a small amount. As described above, the enzyme preparation containing nucleoside phosphorylase of the present invention contains a large amount of nucleoside phosphorylase having high specific activity and heat resistance, and contains a large amount of nucleoside phosphorylase per unit weight of bacterial cell.
  • thermophilic bacterium belonging to the genus Bacillus, which has a high enzyme activity. These enzyme preparations are used for the production of nucleosides. It is a very useful and practical method that has the following features.
  • nucleoside phosphorylase with high specific activity.
  • nucleoside can be produced with high yield with a small amount of enzyme.
  • nucleoside phosphorylase whose optimum and stable temperature ranges are relatively high. For this reason, the reaction can be performed at a high temperature, and the inactivation of the enzyme due to contamination of various bacteria and the decomposition of the reaction product can be suppressed.
  • nucleoside phosphorylases it is also possible to obtain a preparation containing both of the enzymes, purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, as nucleoside phosphorylases.
  • the two enzymes work together, and are twice as large as an enzyme preparation containing only one type of nucleoside phosphorylase. Nucleosides can be produced at the above speed. (Prin Nuku Reoshi
  • -Pyrimidine nucleoside individual-- Limidine base
  • the microorganism of the present invention grows at a relatively high temperature and grows at a high growth rate. It is extremely useful as an enzyme preparation or a preparation source for use in nucleoside production because it contains a large amount of an enzyme suitable for the production of a nucleoside.
  • the nucleoside phosphorylase obtained from the microorganism of the present invention has a high specific activity, and has an optimum temperature and a stable temperature range in a relatively high temperature range. They are clearly distinguished. Further, when such an enzyme is used for producing a nucleotide, the above-mentioned effects (1) and (2) are obtained.
  • the purine nucleoside phosphorylase of the present invention is If both enzymes are used, naturally the above-mentioned effect (3) will be achieved.
  • the method for producing a nucleoside of the present invention comprises a large amount of heat-resistant nucleoside phosphorylase belonging to a thermophilic bacterium belonging to the genus Bacillus, which contains a large amount of nucleoside phosphorylase.
  • Enzyme preparations derived from microbial cells of microorganisms with high enzyme activity are used as an enzyme source for the production of nucleosides, and the target nucleosides can be produced with a small amount of enzyme in high yield. This is a very practical method.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

This invention relates to a method of producing a nucleoside by reacting a base donor, a sugar residue donor, and a phosphate donor with one another in the presence of an enzymatic preparation containing a nucleoside phosphorylase to thereby form an N-glycoside linkage between a base portion of the base donor and a sugar residue portion of the sugar residue donor, characterized in that said enzymatic preparation containing a nucleoside phosphorylase is one based on the cells of at least one microorganism selected from among those belonging to thermophilic bacteria of the genus Bacillus and having a high nucleoside phosphorylase activity per unit weight of the cell.

Description

明 細 書 ヌ ク レ オ シ ドの製造法 技 術 分 野  Technical Documents Manufacturing Method of Nucleoside Technical Field

本発明は、 バチルス属に属する好熱菌由来のヌク レオ シ ドホスホリラーゼを含有する酵素調製物を用いたヌク レオシ ドの製造法に関するものである。  The present invention relates to a method for producing a nucleoside using an enzyme preparation containing a nucleoside phosphorylase derived from a thermophilic bacterium belonging to the genus Bacillus.

背 景 技 術  Background technology

ヌク レオシ ド、 リボース - 1 - リ ン酸等の糖残基供与 体と塩基供与体とを酵素的に反応させてヌク レオシ ドを 製造する方法としては、 例えば、 各種プリ ンヌク レオシ ドの製造法 (特公昭 43 - 24475号、 特公昭 43一 28954号、 特公昭 43 - 28955号、 特公昭 43 一 28956号、 特公昭 45 - 1 1 1 1 6号、 特公昭 48 - 14957号、 特開昭 55 - 7 149 5号、 特開 昭 56 - 18599号、 特開昭 56 - 142293号、 特開昭 56 - 1 64793号、 特開昭 56 - 1661 99号、 特開昭 58 - 63393号、 特開昭 58— 94396号、 特開昭 58 - 1 704 93号な ど) 、 各種ピリ ミ ジンヌ ク レオシ ドの製造法 (特公昭 35 - 16478号、 特開昭 56 - 1 02794号、 特 開昭 59 - 21 3397号、 特開昭 60 - 239495 号、 特開昭 60— 239495号など) 、 その他各種の ヌ ク レオ シ ドの製造法 (特開昭 50— 29720号、 特 開昭 57 - 146593号、 特開昭 58 - 1 90396 号、 特開昭 58 - 216696号、 特開昭 59— Methods for producing nucleosides by enzymatically reacting a sugar residue donor such as nucleoside, ribose-1-phosphate or the like with a base donor include, for example, methods for producing various nucleosides. (JP-B-43-24475, JP-B-43-28954, JP-B-43-28955, JP-B-43-28956, JP-B-45-111116, JP-B-48-14957, JP-A-Showa 55-714995, JP-A-56-18599, JP-A-56-142293, JP-A-56-164793, JP-A-56-166199, JP-A-58-63393, JP-A-58-94396, JP-A-58-170493, etc., and methods for producing various pyrimidine nucleosides (JP-B-35-16478, JP-A-56-102794, JP-A-Showa) 59-21331, JP-A-60-239495, JP-A-60-239495, etc.) Methods for producing nucleotides (Japanese Patent Application Laid-Open No. 50-29720, Japanese Patent Application Laid-Open No. 57-146593, Japanese Patent Application Laid-Open No. 58-190396, Japanese Patent Application No. 58-216696, Japanese Patent Application

143599号、 特開昭 59 - 179094号、 特開昭 59 - 213397号、 特開昭 60— 1 20981号、 特開昭 60— 133896号、 特開昭 63 - 31093 号、 特開昭 63— 1 77797号など) などが報告され ている。 143599, JP-A-59-179094, JP-A-59-213397, JP-A-60-1 20981, JP-A-60-133896, JP-A-63-31093, JP-A-63-1 77797).

しかしながら、 これらの酵素的なヌク レオシ ドの製造 法は、 酵素反応特有の基質特異性、 立体選択性などの点 において化学的合成法と比較して優れたものであるが、 酵素の能力が十分でなく収率および収量の点では必ずし も満足できるものではなかった。  However, these enzymatic methods for producing nucleosides are superior to chemical synthesis methods in terms of the substrate specificity and stereoselectivity specific to enzymatic reactions, but the enzyme ability is not sufficient. However, it was not always satisfactory in terms of yield and yield.

また、 常温で反応を行なえば、 雑菌による汚染が原因 と考えられる収率の低下も観察され、 汚染を回避するた めに高温 (例えば 45て以上) で反応を行なうと藓素が 徐々に失活してしまい、 結果的に収率が著しく低下する という問題点もあった。  In addition, if the reaction is carried out at room temperature, a decrease in yield, which is considered to be caused by contamination by various bacteria, is also observed. There was also a problem that the yield was remarkably reduced as a result.

一般に、 化合物の合成は生成反応と分解反応との平衡 が生成反応に傾く ことによってもたらされるものである, このため、 化合物の収率および収量を高めるためには、 生成反応を促進し、 かつ分解反応を抑制することが肝要 であり、 この原則は酵素的な化合物の製造法においても 例外ではない。 また、 反応温度を高くすれば、 反応速度が速く なり、 短時間のうちに反応が終了し、 かつ基質の溶解性も高ま ることから、 目的化合物を収率よく製造できる可能性を 有している。 In general, the synthesis of a compound is brought about by the fact that the equilibrium between the production reaction and the decomposition reaction is inclined toward the production reaction.Therefore, in order to increase the yield and yield of the compound, the production reaction must be promoted and the decomposition It is essential to suppress the reaction, and this principle is no exception in the production of enzymatic compounds. In addition, when the reaction temperature is increased, the reaction rate is increased, the reaction is completed in a short time, and the solubility of the substrate is also increased. ing.

ヌク レオシ ドホスホリラーゼを用いてヌク レオシ ドを 製造する場合、 ヌク レオシ ドの生成反応を促進するため には'、 触媒として使用する酵素自体の能力および反応条 件の 2つの点から考慮しなければならない。 反応条件の 選定は使用する酵素の能力を引き出すための補助的な手 段にすぎず、 生成反応を促進し、 目的化合物の収率を高 めるための抜本的な方法は優れた能力を有するヌク レオ シ ドホスホリラーゼを用いることである。  When producing nucleosides using nucleoside phosphorylase, two factors must be considered in order to accelerate the nucleoside production reaction: the ability of the enzyme itself to be used as a catalyst and the reaction conditions. No. The selection of reaction conditions is only a supplementary step to bring out the ability of the enzyme to be used, and a drastic method for promoting the production reaction and increasing the yield of the target compound has excellent ability. This is to use nucleoside phosphorylase.

ヌク レオシ ドの製造に使用されている従来のヌク レオ シ ドホスホリラーゼは、 調製の容易な微生物から調製し たものが大多数である。 しかし、 反応の効率、 比活性、 耐熱性、 目的化合物の収率などから酵素の能力を検討し た場合、 従来使用されているものは必ずしも満足できる ものではなかった。  Most of the conventional nucleoside phosphorylases used for the production of nucleosides are prepared from microorganisms that can be easily prepared. However, when the ability of the enzyme was examined from the viewpoints of reaction efficiency, specific activity, heat resistance, yield of the target compound, etc., those conventionally used were not always satisfactory.

—方、 製造したヌク レオシ ドの分解反応に関与すると 考えられる酵素、 例えばヌク レオシダーゼに関しては光 硬化樹脂を用いた固定化法によるヌク レオシダーゼの抑 制法が報告されている (特開昭 6 2— 2 5 3 3 9 3号) , 該方法は優れた方法であるが、 酵素調製物として微生物 菌体を使用する場合には微生物によっては固定化しにく いものもあり、 汎用性に欠ける方法であった。 On the other hand, with regard to enzymes considered to be involved in the decomposition reaction of the produced nucleosides, for example, nucleosidase, a method for suppressing nucleosidase by immobilization using a photocurable resin has been reported (Japanese Patent Application Laid-Open No. — 25 3 3 9 3), This method is an excellent method, but it is difficult to immobilize some microorganisms when using microbial cells as an enzyme preparation. Some methods were not so versatile.

本発明者らは、 ヌク レオシ ドの酵素的製造に使用でき る能力の優れた酵素を発見するため種々の微生物をスク リ一二ングした結果、 バチルス属に属する好熱菌の中に 極めて比活性が高く、 耐熱性のあるヌク レオシ ドホスホ リラーゼを多量に含有し、 菌体単位重量当りのヌク レオ シ ドホスホリラーゼ活性が高い微生物群を発見した。  The present inventors screened various microorganisms to find an enzyme having excellent ability to be used for enzymatic production of nucleosides. We discovered a group of microorganisms that contain high levels of nucleoside phosphorylase with high activity and thermostability and high nucleoside phosphorylase activity per unit weight of cells.

従来、 バチルス属に属する好熱菌であるバチルス · ス テアロザーモフィ スからヌク レオシ ドホリホ リ ラーゼが 単離精製されて、 その酵素的性質が検討報告されている (J. Biol . Chem.. 244, 3891〜3697 (1969) 、 Agric. Biol . Chera. ,53, 2205〜 2210 (1989年 8月 23日) 、  Heretofore, nucleoside dofoliphorylase has been isolated and purified from Bacillus stearothermophilus, a thermophilic bacterium belonging to the genus Bacillus, and its enzymatic properties have been studied and reported (J. Biol. Chem .. 244, 3891). ~ 3697 (1969), Agric. Biol. Chera., 53, 2205-2210 (August 23, 1989),

Agric. Biol . Chem.. 53, 3219〜 3224 (1989年 12月 23-日) 参照) 。 また、 ノくチルス · ステアロザーモフィ ラスの微 生物菌体を酵素源として用いた 5 - メチルゥリ ジンまた はチミ ジンの製造法も報告されている (特開苹 1 一 3 2 0 9 9 5号公報 ( 1989年 12月 27日公開) 、 Agric. Biol . Chem, , 53. 197〜 202 (1989 年 1 月 23日) 参照) 。 しかしながら、 上記報告のヌク レオシ ドホスホリラーゼ は、 耐熱性を有するという利点は有するものの、 比活性 が低く、 かつ菌体単位重量当りの酵素活性も低いために ヌク レオシ ドを収率よく製造することができないという 従来の問題点を解決するまでには至らなかった。 すなわ ち、 特開苹 1 - 3 2 0 9 9 5号公報に記載されているヌ ク レオシ ドの収率を使用した塩基供与体に対する割合で 表わせば、 せいぜい 3 0 %前後 (理想的に反応したとし ても酵素反応の平衡定数から求められる目的物の収率は 5 3〜 5 6 %である) である。 Agric. Biol. Chem .. 53, 3219-3224 (December 23-1989))). In addition, a method for producing 5-methylperidine or thymidine using microbial cells of Noctilus stearothermophilus as an enzyme source has been reported (Japanese Patent Application Laid-Open No. 11-23095). No. Gazette (published on December 27, 1989), Agric. Biol. Chem,, 53. 197-202 (January 23, 1989)). However, although the nucleoside phosphorylase reported above has the advantage of having heat resistance, it has a low specific activity and a low enzyme activity per unit weight of bacterial cells, so that it is possible to produce nucleosides in good yield. It was not enough to solve the conventional problem of not being able to do so. That is, the nucleus described in Japanese Patent Application Laid-Open No. 1-32095 If the yield of the nucleoside is expressed as a ratio to the base donor used, at most around 30% (even if it is ideally reacted, the yield of the target product obtained from the equilibrium constant of the enzyme reaction is 53 to 5%). 6%).

発 明 の 開 示  Disclosure of the invention

発明者らは、 前述の本発明者らの発見した比活性が高 く、 耐熱性のあるヌ ク レオシ ドホスホリラーゼを多量に 含有し、 菌体単位重量当りのヌ ク レオシ ドホスホリラー ゼ活性の高い微生物群に関してさらに研究を重ねた結果、 ①これらの微生物群は、 比活性が高く、 耐熱性のあるプ リ ンヌク レオシ ドホスホリラ一ゼとピリ ミ ジンヌク レオ シ ドホスホリラーゼを合わせ持ち、 かつヌク レオシダー ゼを含有していないか、 含有していてもヌク レオシ ドを 製造する際の反応温度 ( 3 5〜 8 0て) においては極く 微弱な活性しか示ざないものであるこ と、 および②この 微生物群の 1種もしく は 2種以上の微生物の菌体由来の ヌク レオシ ドホスホリラーゼを含有する酵素調製物をヌ ク レオシ ドの酵素的製造に使用すればわずかな酵素量で 短時間に収率よく ヌク レオシ ドを製造することができる ことを知見して本発明を完成させた。  The present inventors have found that a microorganism containing a large amount of thermostable nucleoside phosphorylase having high specific activity and high heat resistance, and having high nucleoside phosphorylase activity per unit weight of bacterial cells, as described above. As a result of further study on the group, ① These microorganisms have high specific activity, heat-resistant nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, and contain nucleosidase. Not exhibiting any very weak activity at the reaction temperature (35-80) during the production of nucleosides, even if it is contained, and The use of enzyme preparations containing nucleoside phosphorylase from the cells of one or more microorganisms for the enzymatic production of nucleosides requires only a small amount. And found that it is possible to produce a good yield quinuclidine Reoshi de in a short time the amount of enzyme and completed the present invention.

すなわち、 本発明は塩基供与体、 糖残基供与体および リ ン酸供与体をヌク レオシ ドホスホリ ラーゼ調製物を用 いて反応させ、 塩基供与体の塩基部分と糖残基供与体の 糖部分との間に N - グリ コシ ド結合を形成させてヌク レ ォシ ドを製造する方法において、 ヌク レオシ ドホスホリ ラーゼを含有する酵素調製物として、 バチルス属に属す る好熱菌のうち、 菌体単位重量当りのヌ ク レオシ ドホス ホリラーゼ活性の高い微生物群の 1種または 2種以上の 微生物の菌体に由来するものを用いることを特徵とする ヌク レオシ ドの製造法に関するものである。 That is, in the present invention, a base donor, a sugar residue donor, and a phosphate donor are reacted using a nucleoside phosphorylase preparation, and the base moiety of the base donor and the sugar moiety of the sugar residue donor are reacted. An N-glycosidic bond is formed between In the method for producing a phosphide, a nucleoside phosphorylase-containing enzyme preparation is selected from the group consisting of one of thermophilic bacteria belonging to the genus Bacillus which has a high nucleoside phosphorylase activity per unit weight of the bacterial cell. The present invention relates to a method for producing a nucleoside, which is characterized by using a substance derived from the species of two or more microorganisms.

なお、 本明細書において 「ヌ ク レオシ ド」 とは、 ゥリ ジン、 チミ ジン、 シチジン、 アデノ シン、 グアノ シンな どの天然に存在するヌク レオシ ドのほか各種のヌク レオ シ ドアナログをも包含する範囲を指称するものである。 また、 本発明は、 上記酵素調製物自体、 該酵素調製物 を調製するために使用する新規な微生物、 該微生物から 調製され、 ヌク レオシ ドの製造にも使用できる新規なヌ ク レオシ ドホスホリラーゼに関するものである。  As used herein, the term "nucleoside" includes naturally occurring nucleosides such as peridine, thymidine, cytidine, adenosine, and guanosine, as well as various nucleoside analogs. This indicates the range to perform. The present invention also relates to the above enzyme preparation itself, a novel microorganism used for preparing the enzyme preparation, and a novel nucleoside phosphorylase prepared from the microorganism and which can be used for production of nucleoside. Things.

図面の簡単な説明  BRIEF DESCRIPTION OF THE FIGURES

第 1図は本発明のプリ ンヌク レオシ ドホスホリラ一ゼ の至適 p Hおよび安定 p H範囲を示したものである。 第 2図は本発明のプリ ンヌク レオシ ドホスホリラーゼ の至適温度および安定温度範囲を示したものである。 第 3図は本発明のピリ ミ ジンヌ ク レオシ ドホスホリラ 一ゼの至適 p Hおよび安定 p H範囲を示したものである 第 4図は本発明のピリ ミ ジンヌク レオシ ドホスホリラ 一ゼの至適温度および安定温度範囲を示したものである 第 5図は、 バチルス * ステアロザーモフィ ラス T H 6 — 2とブレビバクテリ ゥム · ァセチリカム AT 6— 7と を酵素源と して使用して 1一 S— D—リボフラノ シルー 1, 2 , 4一 ト リァゾールー 3—カルボキサミ ド (リバ ピリ ン) を製造した時の反応時間におけるリバピリ ンの 生成率を比較したものである。 FIG. 1 shows the optimum pH and stable pH range of the purine nucleoside phosphorylase of the present invention. FIG. 2 shows the optimum temperature and stable temperature range of the purine nucleoside phosphorylase of the present invention. FIG. 3 shows the optimum pH and the stable pH range of the pyrimidine nucleoside phosphorylase of the present invention. FIG. 4 shows the optimum temperature and the optimum temperature of the pyrimidine nucleoside phosphorylase of the present invention. Fig. 5 shows the stable temperature range. —2 and Brevibacterium acetylicum AT 6-7 were used as enzyme sources to produce 11-S-D-ribofuranosyl 1,2,4-triazole-3-carboxamide (rivapyrin). It is a comparison of rivapirin production rates at different reaction times.

発明を実施するための最良の形態 I ヌク レオシ ドホスホリラーゼを含有する酵素調製物 本発明の 「ヌク レオシ ドホスホリラーゼを含有する酵 素調製物」 (以下、 「酵素調製物」 と称する) とは、 プ リ ンヌク レオシ ドホスホリラーゼまたはピリ ミ ジンヌク レオシ ドホスホリラーゼの少なく とも一方、 好ま しく は 両方のヌク レオシ ドホスホリラーゼを含有するものを指 称する。  BEST MODE FOR CARRYING OUT THE INVENTION I. Enzyme Preparation Containing Nucleoside Phosphorylase The “enzyme preparation containing nucleoside phosphorylase” (hereinafter referred to as “enzyme preparation”) of the present invention includes: The term refers to those containing at least one of nucleoside phosphorylase or pyrimidine nucleoside phosphorylase, but preferably both nucleoside phosphorylases.

また、 「酵素の精製度合」 とは、 総蛋白量に占める酵 素蛋白量の割合を意味する。  The term “degree of purification of the enzyme” means the ratio of the amount of the enzyme protein to the total amount of the protein.

本発明の酵素調製物は、 バチルス属に属する好熱菌、 具体的にはバチルス ♦ ァシ ドカルダリアス (Bacil lus acidocaldarius) ヽ ノくチノレス · シエ レエゲリ (Bacillus schlegeli ) 、 バチルス * ステアロザーモフ ィ ラス (Bacil lus stearotherniophi lus ) などの中等度好熱菌 に属する微生物のうち、 菌体単位重量当りのヌク レオシ ドホスホリラーゼ活性が高い微生物群の微生物 (以下、 本発明の微生物という) より調製することができる。  The enzyme preparation of the present invention includes thermophiles belonging to the genus Bacillus, specifically, Bacillus It can be prepared from microorganisms belonging to a group of microorganisms having high nucleoside phosphorylase activity per unit weight of cells (hereinafter referred to as microorganisms of the present invention) among microorganisms belonging to moderately thermophilic bacteria such as stearotherniophilus).

微生物を選定するためのヌク レオシ ドホスホリラーゼ 活性は、 例えば、 以下の値が一応の目安となる。 Nucleoside phosphorylase for selecting microorganisms For the activity, for example, the following values are a rough guide.

♦ プリ ンヌ ク レオシ ドホスホリ ラ一ゼ  ♦ Prin nucleoside phosphorylase

1 O UZg湿菌体以上、 好ま しく は 1 2 U/g湿 菌体以上  1 O UZg wet cells or more, preferably 12 U / g wet cells or more

· ピリ ミ ジンヌ ク レオシ ドホスホ リラーゼ  · Pyrimidine nucleoside phosphorylase

1 湿菌体以上、 好ま しく は 1 5 UZg湿 菌体以上  1 wet cell or more, preferably 15 UZg wet cell or more

これらの 2つの条件のうち一方を满足するものは本発 明方法に使用する酵素調製物の調製源と して使用するこ とができ、 上記の 2つの条件を同時に満足するものは酵 素調製物の調製源として好適である。  Those satisfying one of these two conditions can be used as a preparation source of an enzyme preparation used in the present invention, and those satisfying both of the above two conditions at the same time It is suitable as a preparation source for products.

そのような条件を満足する好適な微生物を具体的に例 示すれば、 バチルス · ステアロザー乇フィ ラス TH 6 一 2、 同 P— 21、 同 P— 23など (いずれもャマサ醤 油㈱敷地内の土壌より分離した土壌分離菌株) を例示す ることができる。 その菌株群の中の最も代表的な菌株で ある T H 6— 2株の菌学的性質を以下に示す。 Specific examples of suitable microorganisms satisfying such conditions include Bacillus stearothera (Philas TH62, P-21 and P-23) (both in the hamasa soy sauce premises) (Soil isolates isolated from soil). The bacteriological properties of the TH6-2 strain, which is the most representative strain of the strain group, are shown below.

H 6 - 2の菌学的性質 :  Mycological properties of H 6-2:

(Α) 形 態  (Α) Shape

① 細胞の形および大きさ  ① Cell shape and size

短桿状 (Rod ) 、 0. 6〜: L . 1 2〜7 111 Short rod (Rod), 0.6-: L.12-7111

② 胞子の有無 有 ② Spore presence Yes

③ 胞子のうの膨化の有無 有  ③ Spore-sac swelling Yes

④ 細胞内の胞子の部位および大きさ 末端部または中央部、 0. 8 X 0. 8〜: L. 0 m ⑤ グラム染色性 部位 Location and size of intracellular spores Terminal or central, 0.8 X 0.8-: L. 0 m ⑤ Gram stainability

グラムバリ アブル (培養初期はグラム陽性)  Gram variable (Gram positive at the beginning of culture)

(B) 各培地での生育状態  (B) Growth status in each medium

① 肉汁寒天斜面培地  ① Gravy agar slant medium

生育の様相 : 生育旺盛、 表面平滑、 不透明、 培地変 化なし  Growth aspect: vigorous growth, smooth surface, opaque, no change in medium

② 肉汁寒天平板培地  ② Gravy agar plate medium

生育の様相 : 円形コロニー形成、 薄く広がる、 粘性 を示す、 不透明、 周縁波状  Growth aspect: Round colony formation, thin spread, viscous, opaque, fringing

③ リ トマス · ミルク培地  ③ Litmus · Milk medium

生育せず  Do not grow

( C ) 生理的性質  (C) Physiological properties

① 酸素存在下での生育 : 生育する  ① Growing in the presence of oxygen: Growing

② 酸素非存在下での生育 : 生育せず  ② Growth in the absence of oxygen: No growth

③ カタラーゼ : 陽性  ③ Catalase: positive

④ V— Pテス ト : 陰性  ④ V—P test: negative

⑤ メチルレッ ドテス ト (pH in V-P broth): <pH6 メ チ ル Methyl red test (pH in V-P broth): <pH6

⑥ 加水分解能 カゼイ ン : 陰性 加 水 Hydrolytic capacity casein: negative

ゼラチン : 陽性 デンプン : 陽性  Gelatin: Positive Starch: Positive

⑦ クェン酸の利用 : 陽性  ⑦ Use of citrate: positive

⑧ 硝酸塩の還元 : 陽性  硝酸 Nitrate reduction: positive

⑨ イ ン ドールの生成 : 陰性  ⑨ Indole formation: negative

⑩ 塩化ナ ト リ ウムまたは 塩化力リ ゥムの要求性 : 陰性 ナ Sodium chloride or Requirement of chloride room: Negative

Θ 糖質からの酸の生成  酸 Acid production from carbohydrates

陽性 : グルコース、 ァラ ビノース、 キシロース、 フラク トース、 マル トース  Positives: glucose, arabinose, xylose, fructose, maltose

陰性 : デンプン、 グリセロール、 ショ糖、 ラフィ ノース  Negative: starch, glycerol, sucrose, raffinose

© 各 p Hによる生育  © Growth at each pH

6. 8で生育、 5. 7で生育せず  Growing at 6.8, not growing at 5.7

⑬ 塩化ナ ト リ ゥム存在下での生育  生 Growth in the presence of sodium chloride

2 %N a C 1存在下: 生育する  In the presence of 2% Na C 1: grows

5 %N a C 1存在下 : 生育せず  In the presence of 5% Na C 1: Does not grow

Θ 生育範囲  範 囲 Growth range

生育 P H範囲 : 6. 5〜9. 0  Growth PH range: 6.5 to 9.0

生育温度範囲 : 3 5〜6 5で  Growing temperature range: 35 to 65

グルコース存在下での生育  Growth in the presence of glucose

グルコース 0. 5 %以上の存在下で生育せず これらの菌学的性質を Bergey 's Manual of Systematic Bacteriology (第 8版) の分類基準と照合したとこ ろ、 本分離菌はバチルス ♦ ステアロザーモフィ ラスに属 するものであることが判明し、 バチルス ♦ ステアロザー モフィ ラス TH 6— 2と命名した。 また P— 2 1、 P 一 23 も同じ菌学的性質を示した。 なお、 TH 6— 2は 工業技術院微生物工業技術研究所にブタぺス ト条約に基 づいて寄託されており、 受託番号として微ェ研条寄第 2 7 5 8号が与えられている。 この国際寄託は、 1989年 2月 4 日に上記寄託機関に国内寄託された微ェ研菌寄第 10526 号より 1990年 2月 16日に移管したものである。 Glucose did not grow in the presence of 0.5% or more. When these mycological properties were checked against the classification criteria of Bergey's Manual of Systematic Bacteriology (8th edition), the isolated bacteria were Bacillus ♦ stearoser. It was found to belong to the morphophilus, and was named Bacillus ♦ stearoser morphiras TH 6-2. P-21 and P123 also showed the same mycological properties. TH-6-2 has been deposited with the Institute of Microbial Industry and Technology of the National Institute of Advanced Industrial Science and Technology under the Budapest Treaty. No. 2 758 is given. This international deposit was transferred on February 16, 1990 from No. 10526, deposited on the depository organization in Japan on February 4, 1989.

T H 6— 2、 P— 2 1、 P— 2 3はいずれもバチルス ♦ ステアロザー乇フィ ラスに属するものであるが、 菌体 単位重量当りのヌク レオシ ドホスホリ ラーゼ活性が非常 に高く、 かつヌク レオシダーゼを実質的に含有していな い点で公知の微生物とは明確に区別される。 例えば、 ァ メ リ カ ン ♦ タイプ♦ カルチャー ' コ レク ショ ン ( ATCC) に保存されている公知のバチルス · ステアロザーモフィ ラスに属する微生物と、 上記本分離菌とを用いて菌体単 位重量当りのビリ ミ ジンヌク レオシ ドホスホリラ一ゼぉ よびプリ ンヌク レオシ ドホスホリ ラーゼ活性を比較検討 したところ、 その結果は第 1表の通りであった。 第 1表 から、 丁 H 6— 2、 P — 2 1および P— 2 3の菌体単位 重量当りのヌ ク レオシ ドホスホリ ラーゼ活性は、 従来公 知の菌株の保有する酵素活性と比較してプリ ンヌク レオ シ ドホスホリラーゼ活性で 2倍弱およびピリ ミ ジンヌク レオシ ドホスホリラーゼ活性で 6倍強程度それぞれの活 性が高いことがわかる。 具体的には、 上記の本分離菌は、 菌体単位重量当りのプリ ンヌ ク レオシ ドホスホリラーゼ 活性およびピリ ミ ジンヌク レオシ ドホスホリ ラーゼ活性 はそれぞれ 1 3〜 1 5 U / g湿菌体および 2 0 ~ 2 2 U / 湿菌体の値を示すものであった。 第 1 表 TH 6-2, P-21, and P-23 all belong to the Bacillus ♦ stearoser philus, but have a very high nucleoside phosphorylase activity per unit weight of bacterial cells and have a high level of nucleosidase activity. It is clearly distinguished from known microorganisms in that it does not substantially contain it. For example, using a known microorganism belonging to Bacillus stearothermophilus stored in the American ♦ Type ♦ Culture 'Collection (ATCC) and the above isolated bacteria, cell units can be used. Table 1 shows the results of a comparative study of the activity of bilimidine nucleoside phosphorylase and purine nucleoside phosphorylase per weight. From Table 1, it can be seen that the nucleoside phosphorylase activity per unit cell weight of D-H6-2, P-21 and P-23 is higher than that of the previously known strains. It can be seen that the activity is slightly less than 2-fold for nucleoside phosphorylase activity and slightly more than 6-fold for pyrimidine nucleoside phosphorylase activity. Specifically, the above isolated bacteria have a purine nucleoside phosphorylase activity and a pyrimidine nucleoside phosphorylase activity per unit cell weight of 13 to 15 U / g wet cells and 20 to 50 U / g, respectively. The value of 22 U / wet cells was shown. Table 1

Figure imgf000014_0001
Figure imgf000014_0001

したがって、 本分離菌は前述したヌ ク レオシ ドホスホ リ ラーゼ活性の選定基準を十分に満足するものであり、 ヌク レオシ ドを製造するために使用する酵素調製物の調 製源として有用である。 Therefore, this isolated bacterium sufficiently satisfies the selection criteria for nucleoside phosphorylase activity described above, and is useful as a preparation source for an enzyme preparation used for producing nucleosides.

このことを証明するために、 リバビリ ンを製造し、 目 的化合物の生成率を公知菌株と比較してみた。 その結果、 第 2表に示すように、 本発明微生物群に属する微生物を 使用した場合にはいずれも 9 0 %以上の生成率を示すの に対して、 公知の微生物は最高でも 4 0 %の生成率しか 示さず、 本発明の微生物群に属する微生物はヌク レオシ ドの製造のための酵素源と して極めて有用であることを 確認した。 To prove this, we produced ribavirin and compared the production rate of the target compound with known strains. As a result, as shown in Table 2, when microorganisms belonging to the microorganism group of the present invention were used, all of them showed a production rate of 90% or more, while known microorganisms showed a production rate of at most 40%. Only the production rate was shown, and it was confirmed that the microorganism belonging to the microorganism group of the present invention is extremely useful as an enzyme source for producing nucleosides.

第 2 表 Table 2

リノ ピリンの賊率 (%) 使 用 微 生 物 く対 1, 2, 4 - トリァ ゾール- 3 -カルボキ サミ ド比 > Rinopyrine pirates (%) Ratio of microorganisms used to 1,2,4-triazole-3-carboxamide>

^9enJimS.W 丄 Jl一 b— 95. 0 ^ 9e n JimS.W 丄 Jl one b— 95.0

"D つ 1 ヽ u  "D one 1 u

" CP— 23) 94. 1  "CP—23) 94. 1

•A i しし / y づ Q  • A i

· O  · O

〃 " Q U Π Π U 30. 3  〃 "Q U Π Π U 30. 3

〃 丄 u丄 4 y 11. 7  〃 丄 u 丄 4 y 11.7

// 1丄 Π u 1丄 o 44. 4  // 1 丄 Π u 1 丄 o 44. 4

〃 12976 8. 0  〃 12976 8.0

〃 12978 43. 5  〃 12978 43.5

〃 12980 0  〃 12980 0

〃 15952 39. 0  〃 15952 39.0

〃 21365 37. 6  〃 21365 37. 6

〃 29609 4. 1 なお、 上記の比較試験において、 微生物の菌体は後述 の実施例 1と同様にして調製し、 プリ ンヌク レオシ ドホ スホリラ一ゼ活性およびピリ ミ ジンヌク レオシ ドホスホ リ ラーゼ活性の測定は後述の力価の測定法に準じて行つ た。 また、 リバピリ ンは、 基質溶液 (4 O mM 1, 2, 4 - ト リァゾール - 3 - カルボキサミ ド、 60 m Mゥ リ ジン、 40 m Mリ ン酸ニ水素力 リ ゥムを含有する p H 6. 0の水溶液) 1 Omlに菌体重量をそろえた菌体懸濁 液 1 Oml (湿菌体として 200 nigを含有) を添加して 50てで 24時間攪拌することにより製造した。 上記反 応後、 反応液を遠心分離し、 上清を 50〜 1 00倍に希 釈して、 これを H P L C法 (カラム : YMC A 〃 29609 4.1 In the above comparative test, the cells of the microorganism were prepared in the same manner as in Example 1 described below, and the measurement of the activity of prinnucleoside phosphophorylase and pyrimidine nucleoside phosphorylase was performed using the titer described below. The measurement was performed according to the method described in In addition, livapirine is prepared by using a substrate solution (pH containing 40 mM 1,2,4-triazole-3-carboxamide, 60 mM resin, 40 mM dihydrogen phosphate). 6.0 aqueous solution) The suspension was prepared by adding 1 Oml (containing 200 nig as wet cells) of a cell suspension in which the cell weight was adjusted to 1 Oml, and stirring at 50 for 24 hours. After the above reaction, the reaction solution was centrifuged, and the supernatant was diluted 50- to 100-fold, and this was subjected to the HPLC method (column: YMC A

- 31 2 (㈱山村化学研究所製) 、 溶出剤 : 0. 1 5M リ ン酸ニ水素力リ ゥム溶液、 検出 : 220 n mの吸収) でリバピリ ンの生成量を測定した。 -3122 (manufactured by Yamamura Chemical Laboratory), eluent: 0.15M dihydrogen phosphate solution in water, detection: absorption at 220 nm), and the amount of rivapirine was measured.

生成率は次式により求めた。 生成したリバビリ ンの濃度 (M)  The generation rate was determined by the following equation. Concentration of generated ribavirin (M)

生成率(¾) = X 100  Generation rate (¾) = X 100

使用した 1, 2, 4 - トリ ァーゾール - 3 -カルボキ サミ ドの濃度 (M) 本発明の酵素調製物は、 本発明の微生物群に属する微 生物を培養し、 培養して得られた菌体を使用目的に応じ た使用態様に適宜処理加工することにより調製すること ができる。 微生物を培養するための培地としては、 これらの微生 物が資化可能な炭素源および窒素源を適当量含有し、 必 要に応じて金属塩、 微量発育促進物質、 消泡剤などを添 加したものが使用される。 具体的には、 培地成分と して は糖類 (グルコース、 サッカロースなど) 、 天然炭水化 物 (糖蜜、 廃糖蜜、 澱粉、 麦、 ふすま、 米など) 、 アル コール類、 脂肪酸類、 炭化水素類など、 窒素源としては、 肉エキス、 酵母エキス、 大豆加水分解物、 カザミ ノ酸、 各種アミ ノ酸、 尿素など、 無機塩としては亜鉛、 鉄、 マ グネシゥム、 ナ ト リ ウム、 カルシウム、 カ リ ウムなどの 金属のりん酸塩、 塩酸塩、 硫酸塩など、 微量発育促進物 質としてはビタ ミ ン 8 丄、 ビタ ミ ン B 2、 ノ、 'ン トテン酸、 ピオチンなどが例示される。 Concentration of 1,2,4-triazole-3-carboxamide used (M) The enzyme preparation of the present invention is obtained by culturing a microorganism belonging to the microorganism group of the present invention and culturing the cells. Can be prepared by appropriately processing into a use form according to the purpose of use. A culture medium for culturing microorganisms contains an appropriate amount of a carbon source and a nitrogen source which can be assimilated by these microorganisms, and if necessary, a metal salt, a trace growth promoting substance, an antifoaming agent, etc. The added one is used. Specifically, medium components include sugars (glucose, saccharose, etc.), natural carbohydrates (molasses, molasses, starch, wheat, bran, rice, etc.), alcohols, fatty acids, hydrocarbons Nitrogen sources include meat extract, yeast extract, soy hydrolyzate, casamino acids, various amino acids, urea, etc.Inorganic salts include zinc, iron, magnesium, sodium, calcium, calcium Examples of trace growth-promoting substances, such as phosphates, hydrochlorides, and sulfates of metals such as chromium, include vitamin 8 2, vitamin B 2 , amino, pentatothenic acid, and biotin.

培養は、 通常の液体培養法 (振澄培養、 通気攪拌培養、 静置培養、 連続培養など) によって行えばよい。  Culture may be performed by a conventional liquid culture method (eg, supernatant culture, aeration-agitation culture, stationary culture, or continuous culture).

培養条件は、 微生物および培地の種類によって異なり、 特定することはできない。 通常は、 培養開始の p Hを 6 . 5〜 9 . 0に調整し、 約 3 5〜 6 5 °Cの温度条件下 で目的とする酵素活性が十分得られるまで、 具体的には 5〜 5 0時間程度培養する。  Culture conditions vary depending on the microorganism and the type of medium, and cannot be specified. Usually, the pH at the start of the culture is adjusted to 6.5 to 9.0, and the temperature is adjusted to about 35 to 65 ° C until the desired enzyme activity is sufficiently obtained. Incubate for about 50 hours.

このようにして得られる生菌体を含有する培養液 (以 下、 培養物という) を用いて調製する酵素調製物の態様 は特に制限されるものではなく、 例えば、 微生物の培養 物自体、 培養物から通常の分離手段 (遠心分離、 沈澱分 - 1 1 - The embodiment of the enzyme preparation prepared using the culture solution containing the viable cells thus obtained (hereinafter referred to as culture) is not particularly limited. For example, the culture of the microorganism itself, culture Normal separation means (centrifugation, sediment -1 1-

離、 凝集分離、 洗浄など) によって分離された生菌体、 またはその菌体処理物を例示することができる。 (Separation, coagulation separation, washing, etc.) can be exemplified.

生菌体の菌体処理物をさらに具体的に例示すれば、 生 菌体を機械的破壊 (ワーリ ング♦ プレンダ一、 フ レンチ ♦ プレス、 ホモジナイザー、 乳鉢などによる) 、 凍結融 解、 乾燥 (凍結乾燥、 風乾、 アセ ト ン乾燥などによる) 、 自己消化 ( トルエン、 酢酸ェチルなどの溶媒処理によ る) 、 酵素処理 (リ ゾチームなどの細胞壁溶解酵素によ る) 、 超音波処理、 浸透圧ショ ック法、 化学的処理 (塩 類溶液、 酸性溶液、 アルカ リ性溶液、 界面活性剤、 キレ — ト剤などによる) などの一般的処理法に従って処理し て得た生菌体の破壊物または生菌体の細胞壁もしく は Z および細胞膜を変性させたもの、 あるいは酵素活性を有 する画分を抽出し、 さ らに、 必要に応じて酵素活性を有 する抽出画分を一般的な酵素精製法 (塩析処理、 等電点 沈澱処理、 有機溶媒沈緞処理、 各種ク ロマ トグラフィ ー 処理、 透析処理などによる) に従って処理して本発明の 目的とする酵素活性を有する画分を分画するこ とによつ て得られる粗酵素または精製酵素を挙げることができる。  More specific examples of processed cells of live cells are mechanical destruction of live cells (using a waling ♦ blender, French ♦ press, homogenizer, mortar, etc.), freeze-thawing, drying (freezing) Drying, air drying, acetate drying, etc.), autolysis (using a solvent such as toluene or ethyl acetate), enzyme treatment (using cell wall lysing enzymes such as lysozyme), ultrasonic treatment, osmotic pressure treatment Destruction of viable cells obtained by treatment in accordance with general treatment methods such as chemical methods, chemical treatment (using salt solution, acidic solution, alkaline solution, surfactant, chelating agent, etc.) Denature the cell wall or Z of living cells and the cell membrane, or extract a fraction with enzymatic activity, and if necessary, extract the extract with enzymatic activity into a common enzyme. Purification method (By salting-out treatment, isoelectric point precipitation treatment, organic solvent precipitation treatment, various chromatographic treatments, dialysis treatment, etc.) to fractionate the fraction having the enzyme activity desired by the present invention. And a crude enzyme obtained by the above method.

このような培養物、 生菌体および菌体処理物は固定化 処理を施さない遊離の状態で使用してもよく、 また包括 法、 架橋法、 吸着法など通常の方法により固定化処理を 施した固定化物として使用してもよい。  Such cultures, viable cells and treated cells may be used in the free state without immobilization treatment, and may be immobilized by ordinary methods such as inclusive method, cross-linking method and adsorption method. It may be used as an immobilized material.

菌体処理物の一態様である精製酵索に関し、 具体的例 を挙げ説明すれば、 本発明微生物群に属するバチルス · ステアロザーモフィ ラス TH 6— 2より抽出精製して 得られたヌク レオシ ドホスホリラーゼは以下の酵素学的 性質を有する。 Regarding the purified yeast cord which is one aspect of the processed bacterial cells, To be more specific, the nucleoside phosphorylase obtained by extraction and purification from Bacillus stearothermophilus TH6-2 belonging to the microorganism group of the present invention has the following enzymatic properties.

( A ) プリ ンヌク レオシ ドホスホリラーゼ  (A) Prin nucleoside phosphorylase

(1) 作 用  (1) Operation

プリ ンヌ ク レオ シ ド + リ ン酸  Prin nucleoside + phosphoric acid

^プリ ン塩基 +ペン トース - 1 - リ ン酸  ^ Purine base + pentose-1-phosphoric acid

本発明のプリ ンヌク レオシ ドホスホリラーゼは、 上記 の加リ ン酸分解反応を触媒する。 このため、 国際酵素分 類の E. C. 2. 4. 2, 1に属する。  The purine nucleoside phosphorylase of the present invention catalyzes the above-mentioned phosphorylation reaction. For this reason, it belongs to E. C. 2.4.2, 1 of the International Enzyme Classification.

(2) 基質特異性  (2) Substrate specificity

各種のプリ ンヌク レオシ ドを基質に加リ ン酸分解反応 を行わせた結果を第 3表に示す。 Table 3 shows the results of phosphorylation of various purine nucleotides as substrates.

9 9

第 3 表 Table 3

基 質 塩基の生成量 相対活性 Base Amount of base generated Relative activity

( n inol/lOfliin) (X) f 丁 J ンン 0. 1 5 5 (n inol / lOfliin) (X) f D J 0.1

2 - "才干ンァ "ノ ンン 0 02-"Sai-chan"

3 - : r才キンァ: rノ シン 0 0 ノ し ノ ノ ノ ノ ン ノレ , ァー 3-: r-year-old: r-no-shin 0 0 no-no-no-non-no-

0 0 ン イノ シン 2. 5 5 1 0 0 0 0 Innosin 2.5 5 1 0 0

2 ' -デォキシィノ シン 2. 54 1 0 02'-doxyinosine 2.54 1 0 0

3 ' -デォキシィ ノ シン 0 0 グアノ シン 2. 1 5 843'-Doxy-no-syn 0 0 Guan-o-sin 2. 1 5 84

2 ' -デォキシグアノ シン 2. 1 8 8 5 2'-Doxyguanosine 2.1.8 8 5

第 3表より、 本発明のプリ ンヌク レオシ ドホスホリラ ーゼは、 試験した範囲内においてはイノ シン、 2' - デ ォキシイノ シン、 グアノ シンおよび 2 ' - デォキシグァ ノ シンに特異的である。 From Table 3, it can be seen that the purine nucleoside phosphorylase of the present invention is specific for inosine, 2'-deoxyinosine, guanosine and 2'-deoxyguanosine within the range tested.

(3) 至適 p Hおよび p H安定性 (3) Optimal pH and pH stability

至適 p Hは p H 7〜8、 安定 p H範囲は p H 5〜 9で ある (第 1図参照) 。  The optimal pH is pH 7-8, and the stable pH range is pH 5-9 (see Figure 1).

(4) 至適温度および温度安定性  (4) Optimum temperature and temperature stability

至適温度は 60〜80°C:、 安定温度範囲 60でまでで ある (第 2図参照) 。  The optimum temperature is 60-80 ° C: the stable temperature range is up to 60 (see Fig. 2).

(5) 分子量  (5) Molecular weight

S D S - ポアク リルア ミ ドゲル電気泳動法で測定した 分子量が約 45000である。 '  The molecular weight is about 45,000 as measured by SDS-Polyacrylamide gel electrophoresis. '

(6) 力価 (比活性)  (6) Titer (specific activity)

80 %の酵素の精製度合で比活性が 400 (U/mg) 以上を示し、 90 %の酵素の精製度合で 450 (U/mg) を示す。  The specific activity is more than 400 (U / mg) at 80% enzyme purification and 450 (U / mg) at 90% enzyme purification.

( B ) ピリ ミ ジンヌ ク レオシ ドホスホ リ ラーゼ  (B) Pyrimidine nucleoside phosphorylase

(1) 作 用  (1) Operation

ピリ ミ ジンヌ ク レオシ ド + リ ン酸  Pyrimidine nucleoside + phosphoric acid

^ピリ ミ ジン塩基 '+ペン トース - 1 - リ ン酸 本発明のピリ ミ ジンヌ ク レオシ ドホスホリ ラーゼは、 上記の加リ ン酸分解反応を触媒する。 このため、 国際酵 素分類の E. C. 2. 4. 2, 2に属する。 (2) 基質特異性 ^ Pyrimidine base '+ pentose-1-phosphoric acid The pyrimidine nucleoside phosphorylase of the present invention catalyzes the above-mentioned phosphorylation reaction. For this reason, it belongs to the International Enzyme Classification EC 2.4.2.2. (2) Substrate specificity

各種のピリ ミ ジンヌク レオシ ドを基質に加リ ン酸分解 反応を行わせた結果を第 4表に示す。  Table 4 shows the results of phosphorylation of various pyrimidine nucleotides as substrates.

第 4 表  Table 4

塩基の生成量 相対活性 ( (1 raol / lOniin) (X) ゥ リ ジン 1. 73 68Base production relative activity ((1 raol / lOniin) (X)) resin 1.73 68

2 ' - デォキシゥ リ ジン 2. 55 1 00 ァラ ビノフラノ シルゥラ シ 0 0 ル シユー ドゥ リ ジン 0 - 0 サイ ク ロウ リ ジン 0 0 シチジン 0 0 一2'-Doxy resin 2.55 1 00 ARA BINOFURANO CYLINDER 0 0 LUCY DOU LIZIN 0-0 CYCLOW LIZIN 0 0 CITIDINE 0 0 1

2 ' - デォキシシチジン 0 0 リボフラノ シルチ ミ ン 0. 96 38 チ ミ ジン 1. 7 1 67 2'-Doxycytidine 0 0 Ribofuranosyl thymine 0.96 38 Thymidine 1.7 1 67

第 4表より、 本発明のピリ ミ ジンヌ ク レオシ ドホスホ リ ラーゼは、 試験した範囲内においてはゥ リ ジン、 2 ' - デォキシゥ リ ジン、 リ ボフラノ シルチ ミ ン、 チ ミ ジン に特異的である。 As shown in Table 4, the pyrimidine nucleoside phosphorylase of the present invention is specific to peridine, 2'-dexoxylysine, ribofuranosylthymine, and thymidine within the range tested.

(3) 至適 p Hおよび p H安定性  (3) Optimal pH and pH stability

至適 p Hは p H 7〜9、 安定 p H範囲は p H 5〜 9で ある (第 3図参照) 。 (4) 至適温度および温度安定性 The optimal pH is pH 7-9, and the stable pH range is pH 5-9 (see Figure 3). (4) Optimum temperature and temperature stability

至適温度は 60〜70で、 安定温度範囲 60°Cまでで ある (第 4図参照) 。  The optimum temperature is 60 to 70, and the stable temperature range is up to 60 ° C (see Fig. 4).

(5) 分子量  (5) Molecular weight

S D S - ポリアク リルアミ ド電気泳動法で測定した分 子量が約 31000である。  The molecular weight measured by SDS-polyacrylamide electrophoresis is about 31,000.

(6) 力価 (比活性)  (6) Titer (specific activity)

80%の酵素の精製度合で比活性が 250 (U/ing) 以上を示し、 90 %の酵素の精製度合で 297 (U/mg) を示す。  The specific activity is more than 250 (U / ing) at 80% enzyme purification and 297 (U / mg) at 90% enzyme purification.

なお、 上記の酵素的性質は以下に示す方法で測定した。 ① 力価の測定 、  The above enzymatic properties were measured by the following methods. ① Measurement of titer,

プリ ンヌ ク レオシ ドホス リラーゼ活性 ― 基質溶液 (20 mMイノ シンおよび 0. 1Mリ ン酸ニ 水素カ リ ウムを含有する p H 8. 0の水溶液) 1. 0ml に酵素溶液 (精製酵素として 1 gを含有する 50 mM 齚酸緩衝液 (p H 6. 0) ) 20 £ を加えて 50eCで 1 0分間反応させた後、 塩酸を最終濃度で 0. I Nにな るように加えて反応停止させるとともに 0でで 10分間 冷却する。 次に、 反応液を遠心分離し、 得られた上清を H P L C法 (カラム : YMC A— 31 2 (㈱山村化学 研究所製) 、 溶出剤 : ァセ トニト リル 5. 0%含有 20 mMト リス -塩酸緩衝液 (p H 7. 5) 、 検出 : 260 n m) で生成するヒポキサンチンを定量する。 1分間に 一 2 Prin nucleoside phosphorylase activity-Substrate solution (pH 8.0 aqueous solution containing 20 mM inosine and 0.1 M potassium dihydrogen phosphate) 1.0 ml of enzyme solution (1 g as purified enzyme) containing 50 mM齚酸after buffer (p H 6. 0)) 20 £ added and reacted for 10 minutes at 50 e C, reaction by adding hydrochloric acid so that such a 0. iN at a final concentration Stop and cool at 0 for 10 minutes. Next, the reaction solution was centrifuged, and the obtained supernatant was subjected to an HPLC method (column: YMC A- 312 (manufactured by Yamamura Chemical Laboratory), eluent: 20 mM toluene containing 5.0% of acetonitrile). Quantify the amount of hypoxanthine produced in squirrel-HCl buffer (pH 7.5), detection: 260 nm). In one minute One two

1 μ mol のヒポキサンチンを生成する酵素量を 1単位1 unit of enzyme producing 1 μmol hypoxanthine

( ru」 ) とする。 (ru)).

ピリ ミ ジンヌク レオシ ドホスホリラーゼ活性  Pyrimidine nucleoside phosphorylase activity

基質溶液中のイノ シンの代わりにゥリ ジンを使用し、 H P L C法でゥラシルを定量する以外は上記のプリ ンヌ ク レオシ ドホスホリラーゼ活性の測定法と同様にして行 う。 1分間に 1 mol のゥラシルを生成する酵素量を 1 単位とする。  The procedure is the same as the above-described method for measuring the phosphoryl phosphorylase activity except that peridine is used instead of inosine in the substrate solution and peracyl is quantified by the HPLC method. One unit is the amount of enzyme that produces 1 mol of peracil per minute.

② 基質特異性  ② Substrate specificity

基質溶液として 1 0 mMの各種ヌク レオシ ドおよび 50 mMのリ ン酸二水素カ リ ウムを含有する p H 8. 0 の水溶液を使用し、 50てで 1 0分間反応させ、 反応後、 H P L C法で各種ヌク レオシ ドの塩基を定量する以外は プリ ンヌク レオシ ドホスホリラーゼ活性の測定法と同様 にして行う。  Using an aqueous solution of pH 8.0 containing 10 mM of various nucleosides and 50 mM of potassium dihydrogen phosphate as a substrate solution, react at 50 ° C for 10 minutes. The procedure is the same as that for the measurement of the activity of purine nucleoside phosphorylase, except that the bases of various nucleosides are quantified by the method.

③ 至適 p H  ③ Optimal pH

ヌク レオシ ド ( 20 m Mのイ ノ シンまたはゥ リ ジン) および 0. 1 Mのリ ン酸ニ水素力 リ ウムを溶解させ、 希 塩酸または希水酸化ナト リ ゥムの各水溶液で p H4〜 1 0に調整した基質溶液を使用した以外はプリ ンヌク レ オシ ドホスホリラーゼ活性の測定法と同様にして行う。 Dissolve nucleosides (20 mM inosine or peridine) and 0.1 M potassium dihydrogen phosphate, and adjust the pH to 4 with an aqueous solution of dilute hydrochloric acid or dilute sodium hydroxide. The procedure is performed in the same manner as in the measurement of the activity of purine nucleotide phosphorylase, except that the substrate solution adjusted to ~ 10 is used.

④ 安定 P H 安定 Stable P H

0. 2Mの酢酸緩衝液 (p H 3. 5〜6) およびト リ ス -塩酸緩衝液 (p H 7〜9) 中で 37でで 16時間保 持した酵素溶液を使用した以外は、 プリ ンヌク レオシ ド ホスホリ ラーゼ活性またはピリ ミ ジンヌク レオシ ドホス ホリラーゼ活性の測定法と同様にして行う。 Store in 0.2M acetate buffer (pH 3.5-6) and Tris-HCl buffer (pH 7-9) at 37 for 16 hours The procedure is the same as that for measuring the activity of purine nucleoside phosphorylase or pyrimidine nucleoside phosphorylase, except that the enzyme solution used is used.

⑤ 至適温度  適 Optimal temperature

反応を 3 0〜8 0での各温度で行う以外はプリ ンヌク レオシ ドホスホリラーゼ活性またはピリ ミ ジンヌク レオ シ ドホスホリラーゼ活性の測定法と同様にして行う。 The reaction is performed in the same manner as in the measurement of the activity of purine nucleoside phosphorylase or pyrimidine nucleoside phosphorylase, except that the reaction is carried out at each temperature of 30 to 80.

⑥ 安定温度範囲 ⑥ Stable temperature range

3 0〜8 0でで 1 5分間加熱した酵素溶液を使用する 以外は、 プリ ンヌク レオシ ドホスホリラーゼ活性または ピリ ミ ジンヌ ク レオシ ドホスホリ ラ一ゼ活性の測定法と 同様にして行う。  Except for using an enzyme solution heated at 30 to 80 for 15 minutes, the measurement is performed in the same manner as in the method for measuring the activity of purine nucleoside phosphorylase or pyrimidine nucleoside phosphorylase.

上述の本発明微生物群中の微生物から得られた酵素の 特徵は、 比較的高温に至適温度と安定温度範囲を持ち、 かつ比活性が著しく高いところにある。 したがって、 こ のような特徵を有する酵素を含有する調製物をヌ ク レオ シ ドの製造に使用すれば、 反応に使用する酵素調製物の 量が少なくてすみ、 わずかな酵素量でヌク レオシ ドを収 率よく製造することができる。 さらに、 反応を比較的高 温 (4 5で以上) で行えるので雑菌微生物による汚染を 防止することもできる。  The characteristics of the enzymes obtained from the microorganisms in the microorganism group of the present invention described above are that they have an optimum temperature and a stable temperature range to a relatively high temperature, and have a very high specific activity. Therefore, if a preparation containing an enzyme having such characteristics is used for the production of a nucleotide, the amount of the enzyme preparation used in the reaction can be reduced, and the nucleotide amount can be reduced with a small amount of the enzyme. Can be manufactured with good yield. Furthermore, since the reaction can be performed at a relatively high temperature (45 or more), contamination by various microorganisms can be prevented.

Π ヌ ク レオシ ドの製造  製造 Manufacture of nucleotides

上述の酵素調製物を用いるヌク レオシ ドの製造は、 反 応容器内において後述の塩基供与体、 糖残基供与体およ びリ ン酸供与体と酵素調製物を接触反応させることによ り実施することができる。 The production of a nucleoside using the above enzyme preparation is carried out in a reaction vessel in the form of a base donor, a sugar residue donor and a sugar residue donor described below. The reaction can be carried out by contacting a phosphoric acid donor with an enzyme preparation.

① 塩基供与体 ① Base donor

本発明方法で使用する塩基供与体は反応系に塩基を供 耠する ものである。 使用する塩基供与体は目的とするヌ ク レオシ ドに応じて選択すればよ く 、 ヌ ク レオシ ドホス ホ リ ラ一ゼの作用によって糖残基供与体の糖部分と N - グリ コシ ド結合を形成しう る複素環塩基またはその誘導 体を例示することができる。 複素環塩基の具体例は、 例 えば、 プリ ンおよびその誘導体、 ピリ ミ ジンおよびその 誘導体、 ト リァゾールおよびその誘導体、 イ ミ ダゾール およびその誘導体、 デァザプリ ンおよびその誘導体、 ァ ザプリ ンおよびその誘導体、 ァザピリ ミ ジンおよびその 誘導体またはピリ ジンおよびその誘導体などである。 ま た、 塩基供与体と しては、 複素環塩基そのものはもとよ り、 該複素環塩基を有するヌ ク レオシ ド、 ヌ ク レオチ ド などであってもよい。  The base donor used in the method of the present invention supplies a base to the reaction system. The base donor to be used may be selected according to the target nucleotide, and the N-glycosidic bond between the sugar moiety of the sugar residue donor and the N-glycosidic bond is formed by the action of nucleoside phosphorylase. Examples of the heterocyclic base to be formed or a derivative thereof can be given. Specific examples of the heterocyclic base include, for example, purine and its derivatives, pyrimidine and its derivatives, triazole and its derivatives, imidazole and its derivatives, azapurine and its derivatives, azapurine and its derivatives, And azapyrimidine and its derivatives or pyridine and its derivatives. In addition, the base donor may be not only the heterocyclic base itself, but also a nucleotide or a nucleotide having the heterocyclic base.

具体的には、 プリ ン塩基の 1位、 2位、 6位または 8 位の 1 または 2以上の位置に置換基 (例えば、 ア ミ ノ基、 置換ァ ミ ノ基、 水酸基、 ォキソ基、 メルカプト基、 ァシ ル基、 アルキル基、 置換アルキル基、 アルコキシル基、 ハロゲノ原子など) を有するプリ ン誘導体、 例えばアデ ニン、 グァニン、 ヒポキサンチン、 キサンチン、 6 - メ ルカプ トプリ ン、 6 - チォグァニン、 Ν σ - アルキルも しく はァシルアデニン、 2 - アルコキシアデニン、 2 - チオアデニン、 2 , 6 - ジァ ミ ノプリ ンなど ; ピリ ミ ジ ンの 2位、 4位または 5位の 1 または 2以上の位置に前 記と同様の置換基を有する ピリ ミ ジン誘導体、 例えば、 シ ト シン、 ゥラ シル、 チ ミ ン、 5 - ノ、ロゲノ ウラ シル ( 5 - フルォロウラ シル、 5 - ョ一 ドウラ シルなど) 、 5 - ハロゲノ シ ト シン ( 5 - フルォロシ ト シンなど) 、 5 - ト リハロゲノメチルゥラ シル ( 5 - ト リ フルォロメ チルゥラ シルなど) 、 2 - チオシ ト シン、 4 - チォゥラ シル、 N 4 - ァシルシ ト シン、 5 - ハロゲノ ビ二ルゥラ シルなど ; 1 , 2, 4 - ト リァゾールの 3位に置換基を 有する 1, 2 , 4 - ト リ ァゾール誘導体、 例えば 1 , 2 , 4 - ト リァゾール - 3 - カルボキサミ ド、 1 , 2, 4 - ト リァゾ一ル - 3 - カルボン酸、 1 , 2, 4 - ト リァゾ ール - 3 - カルボン酸アルキルエステルなど ; ィ ミ ダゾ ールの 4位および 5位に置換基を有するィ ミ ダゾール誘 導体、 例えば 5 - ァミ ノ - 4 - イ ミ ダゾールカルボキサ ミ ド、 4 - カルバモイノレ - イ ミ ダゾリ ゥム - 5 - ォレ一 ト、 ベンズィ ミ ダゾールなど ; プリ ンの 1位、 3位も し く は 7位におけるデァザプリ ン誘導体、 例えば 1 - デァ ザアデニン、 3 - デァザアデ二ン、 3 - デァザグァニン、 7 - デァザアデニン、 7 - デァザグァニンも しく はこれ らに前記プリ ン誘導体と同様の置換基を有する化合物な ど ; 8 - ァザアデニン、 7 - デァザ - 8 - ァザヒポキサ ンチン (ァロプリ ノール) などのァザプリ ン誘導体 ; 5 - ァザチ ミ ン、 5 - ァザシ ト シン、 6 - ァザゥラ シルな どのァザピリ ミ ジン誘導体 ; 3 - デァザゥラ シル、 ニコ チン酸、 ニコチン酸ァミ ドなどのピリ ジン誘導体などが 例示される。 Specifically, a substituent (for example, an amino group, a substituted amino group, a hydroxyl group, an oxo group, a mercapto group) is provided at one or more positions of the 1, 2, 6, or 8 positions of the prim base. Derivatives having a group, an acyl group, an alkyl group, a substituted alkyl group, an alkoxyl group, a halogeno atom), for example, adenine, guanine, hypoxanthine, xanthine, 6-mercaptoprin, 6-thioguanine, Ν σ -alkyl Or acyladenine, 2-alkoxyadenine, 2-thioadenine, 2,6-diaminoprin, etc .; at one or more of the 2-, 4- or 5-positions of pyrimidine, the same as above Pyrimidine derivatives having a substituent, for example, cytosine, peracyl, thymine, 5-no, logenouracil (eg, 5-fluorouracil, 5-hydroxyuracil, etc.), 5-halogenosit Shin (5 - Furuoroshi Toma, etc.), 5 - Application Benefits halogenoalkyl methyl © La sill (5 - Application Benefits Furuorome Chiruura sills etc.), 2 - Chioshi Toma, 4 - Chioura sills, N 4 - Ashirushi Toma, 5 - 1,2,4-triazole derivatives having a substituent at the 3-position of 1,2,4-triazole, for example, 1,2,4-triazole-3-carboxamide, 1,2,4-triazole derivative and the like; , 2, 4-G Azole-3-carboxylic acid, 1,2,4-triazole-3-carboxylic acid alkyl ester, etc .; imidazole derivative having substituents at 4- and 5-positions of imidazole For example, 5-amino-4-imidazolecarboxamide, 4-carbamoinole-imidazole-5-oleate, benzimidazole, etc .; Or a azapurine derivative at the 7-position, e.g., 1- azaadenine, 3- azaadenine, 3- azaguanine, 7- azaadenine, 7- azaguanine, or a substituent similar to the above pyridine derivative. 8-azaazadenine, 7-aza-8-azahipoxa Derivatives such as azapurinol (aroprinol); azapyrimidine derivatives such as 5-azathymine, 5-azacitosine, 6-azaduracil; and azapyrimidine derivatives such as 3-dezaduracil, nicotinic acid, and nicotinic acid amide Examples include pyridin derivatives.

② 糖残基供与体  ② Sugar residue donor

糖残基供与体は反応系に糖残基を供給する ものである。 すなわち、 糖残基供与体と しては目的とするヌ ク レオシ ドに応じて選択すればよく 、 ヌ ク レオシ ドホスホ リラー ゼの作用により塩基供与体の塩基部分と N - グリ コシ ド 結合を形成しう る リ ボース化合物、 デォキシリボ一ス化 合物を例示する ことができる。 リボース化合物と しては、 イ ノ シン、 グアノ シン、 ゥ リ ジン、 リ ボフラノ シルチ ミ ンなどのリ ボヌ ク レオシ ドおよびリ ボース - 1 - リ ン酸 を、 デォキシ リ ボース化合物と しては、 2 ' - デォキ イノ シン、 2 ' - デォキシグアノ シン、 2 ' - デォキシ ゥ リ ジン、 チ ミ ジン、 2 ' , 3 ' - ジデォキシイ ノ シン、 2 ' , 3 ' - ジデォキシグアノ シ ン、 2 ' , 3 ' - ジデ ォキシゥ リ ジン、 3 ' - デォキシチミ ジンなどのデォキ シヌク レオシ ド、 および 2 - デォキシリボース - 1 - リ ン酸、 2 , 3 - ジデォキシリボース - 1 - リ ン酸などを それぞれ例示することができる。  The sugar residue donor supplies a sugar residue to the reaction system. In other words, the sugar residue donor may be selected according to the target nucleotide, and an N-glycosidic bond is formed with the base moiety of the base donor by the action of nucleoside phosphorylase. For example, a ribose compound and a deoxyribose compound can be exemplified. Examples of ribose compounds include ribonucleosides such as inosine, guanosine, peridine, ribofuranosylthymine, and ribose-1-phosphate, and examples of deoxyribose compounds include: 2'-deoxyinosine, 2'-deoxyguanosine, 2'-deoxyperidine, thymidine, 2 ', 3'-dideoxyinosine, 2', 3'-dideoxyguanosine, 2 ', 3' -Doxy nucleosides such as didoxyperidine, 3'-deoxythymidine, and 2-dexoxyribose-1-linoleic acid, and 2,3-dideoxyribose-1-linoleic acid. it can.

また、 酵素調製物として精製酵素以外のものを使用す る場合には、 上記の糖残基供与体に加えて、 さ らにアデ ノ シン、 シチジン、 キサン ト シンなどのリボース化合物、 および 2 ' - デォキシアデノ シン、 2 ' - デォキシシチ ジン、 2 ' - デォキシキサン トシンなどのデォキシリボ —ス化合物も使用しうる可能性を有する。 When an enzyme preparation other than a purified enzyme is used, in addition to the above sugar residue donor, an additional enzyme may be used. Ribose compounds such as nosin, cytidine and xanthosine, and deoxyribose compounds such as 2'-deoxyadenosine, 2'-dexoxytidine and 2'-dexoxyxanthosine have the potential to be used.

③ リ ン酸供与体 ③ Phosphoric acid donor

リ ン酸供与体としては、 反応液中でリ ン酸イオンに解 離しうるもののいずれを用いてもよく、 例えば遊離型の リ ン酸またはリ ン酸塩 (例えば、 ナ ト リ ウム、 カリ ウム などのアルカリ金属塩、 アンモニゥム塩など) が好適に 使用される。 また、 リ ン酸供与体としては、 反応液中で リ ン酸イオンを遊離しうる系、 例えば各種リ ン酸エステ ル誘導体とホスファターゼの組合せ、 ヌク レオチ ドとヌ ク レオチダーゼの組合せなどを利用することもできる。 ④ 反応条件  As the phosphate donor, any one capable of dissociating into phosphate ions in the reaction solution may be used. For example, free phosphate or phosphate (eg, sodium, potassium) Alkali metal salts, ammonium salts, etc.) are preferably used. As the phosphate donor, a system capable of releasing phosphate ions in the reaction solution, such as a combination of various phosphate ester derivatives and phosphatase, or a combination of nucleotide and nucleotidase is used. You can also. ④ Reaction conditions

反応液としては、 塩基供与体、 糖残基供与体およびリ ン酸供与体が水または緩衝液に溶解または懸濁したもの を用い、 この反応液と前述の酵素調製物と接触させて、 使用した塩基供与体に対応するヌク レオシ ドを酵素的に 製造する。  As the reaction solution, a solution prepared by dissolving or suspending a base donor, a sugar residue donor and a phosphate donor in water or a buffer solution is used. The nucleoside corresponding to the base donor is enzymatically produced.

塩基供与体、 糖残基供与体、 リ ン酸供与体の使用濃度 は、 0 . 1〜 5 0 0 m Mの範囲から適宜選定すればよい。 反応は通常、 3 5〜8 CTCの範囲で効率よく進行する が、 特に 4 0〜 7 0て程度の反応温度が好ま しい。 反応 温度が 3 5で以下のときは反応速度が遅く、 反応効率が よく ない。 また、 80 °C以上の反応温度ではヌク レオシ ドホスホリラーゼ活性を低下させるおそれがある。 The concentrations of the base donor, sugar residue donor and phosphoric acid donor used may be appropriately selected from the range of 0.1 to 500 mM. The reaction usually proceeds efficiently in the range of 35 to 8 CTC, but a reaction temperature of about 40 to 70 is particularly preferred. When the reaction temperature is 35 or less, the reaction speed is slow and the reaction efficiency is low. not good. At a reaction temperature of 80 ° C or more, nucleoside phosphorylase activity may be reduced.

反応液の p Hは通常 p H 5〜 1 0、 好ま しく は p H 5 〜 9の範囲に保たれればよい。 反応中に p Hが変動する ときは酸またはアルカ リを用いて好ま しい p H範囲に補 正すればよい。  The pH of the reaction solution is usually maintained in the range of pH 5 to 10, preferably pH 5 to 9. When the pH fluctuates during the reaction, the pH may be adjusted to a preferable pH range using an acid or alkali.

反応後、 反応液と酵素組成物とを分離し、 目的とする ヌク レオシ ドを分離精製工程に供する。  After the reaction, the reaction solution and the enzyme composition are separated, and the target nucleoside is subjected to a separation and purification step.

生成したヌク レオシ ドは公知の方法またはこれを応用 した方法によって分離精製することができる。 例えば、 イオン交換クロマ トグラフィ ー、 吸着ク ロマ トグラフィ ―、 分配ク口マ トグラフィ ー、 ゲル^過法など各種のク 口マ トグラフィ ー、 向流分配、 向流抽出など二液相間の 分配を利用する方法、 濃縮、 冷却、 有機溶媒添加など溶 解度の差を利用する方法などのヌ ク レオシ ドの分離精製 で使用されている一般的な分離精製法を単独で、 あるい は適宜に組合せて行えばよい。  The generated nucleoside can be separated and purified by a known method or a method using the same. For example, use of various liquid chromatography such as ion exchange chromatography, adsorption chromatography, distribution chromatography, gel filtration, counter-current distribution, and counter-current extraction. Common separation and purification methods used in the separation and purification of nucleotides, such as methods that utilize differences in solubility such as concentration, cooling, and addition of organic solvents, etc., alone or in combination as appropriate. Just do it.

〔実施例〕  〔Example〕

以下、 実施例および比較例によって本発明を具体的に 説明する。  Hereinafter, the present invention will be described specifically with reference to Examples and Comparative Examples.

実施例 1 Example 1

薛母エキス(Difco社製) 0. 5%、 ペプ ト ン (D co 社製) 1. 0%、 肉エキス (Difco 社製) 0. 7%およ び食塩 0. 3%を含む殺菌済みの培地 (p H 7. 0 ) 500 mlにバチルス ♦ ステアロザーモフィ ラス TH 6— 2 (微ェ研条寄第 27 58号) を植菌し、 5 TCで 18 時間振盪培養した。 Sterile extract containing 0.5% Suemo extract (Difco), 1.0% peptone (Dco), 0.7% meat extract (Difco) and 0.3% salt Medium (pH 7.0) Bacillus ♦ stearothermophilus TH 6-2 (No. 2758, No. 2758) was inoculated into 500 ml, and cultured with shaking at 5 TC for 18 hours.

得られた培養液を遠心分離して菌体を集菌し、 洗浄後、 殺菌水を加えて 250mlの菌体懸濁液を調製した。 この 菌体懸濁液を 1 0mlずつ分取し、 40 mM塩基供与体、 40 mM糖残基供与体および 40 m Mリ ン酸ニ水素力 リ ゥムを含有する基質溶液 ( p H 6. 0 ) 1 0 mlを添加し て 40〜60でで、 攪拌条件下反応させた。  The obtained culture was centrifuged to collect the cells, and after washing, sterilized water was added to prepare a 250-ml cell suspension. A 10 ml aliquot of this bacterial cell suspension was taken, and a substrate solution (pH 6.6) containing 40 mM base donor, 40 mM sugar residue donor and 40 mM dihydrogen phosphate reagent was prepared. 0) 10 ml was added, and the mixture was reacted at 40 to 60 with stirring.

反応後、 各種ヌ ク レオシ ドの生成量は、 高速液体ク 口 マ トグラフィ ー (カラム : YMC A— 31 2 (㈱山村 化学研究所製) 、 溶出剤 : 2. 5~5%ァセ トニ 卜 リル 含有 2 OmMト リス塩酸緩衝液 (p H 7. 5) 、 検出 : 250〜 260 n mにおける吸収) を用いて測定した。 ヌク レオシ ドの生成率は下記式により求めた。  After the reaction, the amount of various nucleotides produced was determined by high performance liquid chromatography (column: YMC A-312 (manufactured by Yamamura Chemical Laboratory), eluent: 2.5 to 5% acetonitrile The measurement was carried out using a 2 OmM Tris-HCl buffer containing ril (pH 7.5), detection: absorption at 250 to 260 nm. The nucleoside generation rate was determined by the following equation.

生成したヌクレオシドの濃度 (M) 生成率 ) X 100 使用した塩基供与体の濃度 (M) その結果を第 5表に示す, 第 5 表Concentration of generated nucleoside (M) Production rate) X 100 Concentration of base donor used (M) The results are shown in Table 5. Table 5

* ±t /It iH. (± 成 物 反 応 条 件 生成率 (%) * ± t / It iH. (± product reaction condition generation rate (%)

•uni^l レ^ ί^Ί * υ ^ο- レ、 rr • uni ^ l レ ^ ί ^ Ί * υ ^ ο- レ 、 rr

温度 CO 時間 (hr) <対塩腿 > アデニン ゥ リ ジ ン ア デ ノ シ ン 40 24 61 Temperature CO time (hr) <to salt thigh> adenine ゥ resin adenosine 40 24 61

// 50 2 45// 50 2 45

// 〃 〃 50 24 82// 〃 〃 50 24 82

〃 〃 60 2 60 〃 〃 60 2 60

〃 〃 60 24 85 アデニ ン 2' -デ才キシゥリジン 2' -デォキシアデノシン 40 2 25 〃 〃 60 24 85 Adenine 2'-deoxyxidiridine 2'-Doxyadenosine 40 2 25

〃 〃 〃 50 2 55〃 〃 〃 50 2 55

〃 〃 60 2 63〃 〃 60 2 63

〃 〃 〃 60 4 70〃 〃 〃 60 4 70

〃 〃 〃 60 8 78 Ί 、〃 〃 〃 60 8 78 、,

// 2', 3'-ジデ才キシゥリジン 2*.3 '-ジデォキシアデノシン 55 24 151) チ ミ ン ゥ リ ジ ン リボフラノシルチミン 40 2 48// 2 ', 3'-dideoxyxidyridine 2 * .3'-dideoxyadenosine 55 24 15 1 ) thymidine peridine ribofuranosyl thymine 40 2 48

〃 // 〃 50 2 58〃 // 〃 50 2 58

〃 // 〃 60 2 60 〃 // 〃 60 2 60

〃 〃 60 24 65 チ ミ ン 2' -デ才キシゥリジン ナ ン ノ 40 2 23 〃 〃 60 24 65 Thymin 2 '

〃 // 〃 50 2 55〃 // 〃 50 2 55

// // 〃 60 ί 2 66// // 〃 60 ί 2 66

// // 〃 60 8 67// // 〃 60 8 67

1 ) 対糖觀供与体比で示す。 1) Shown in the ratio of sugar to donor.

実施例 2 Example 2

塩基供与体としてァロプリノール 2 0 mM、 糖残基供 与体としてゥリ ジン 3 0 mMおよびリ ン酸二水素力リゥ ム 7 5 mMを含有する基質溶液 ( p H 6. 0 ) を用いて 実施例 1 と同様にして 60 °Cで 8時間反応させてアルプ リノールのリボフラノ シル体を 9 5 %の収率 (対アルプ リ ノール比) で製造した。  Performed using a substrate solution (pH 6.0) containing 20 mM aloprinol as a base donor, 30 mM peridine and 75 mM dihydrogen phosphate as a sugar residue donor. The reaction was carried out at 60 ° C for 8 hours in the same manner as in Example 1 to produce a ribofuranosyl form of alprinol with a yield of 95% (ratio to alprinol).

実施例 3 Example 3

塩基供与体 (ァロプリノール、 ベンズィ ミ ダゾール、 6 - メルカプトプリ ン、 プリ ン、 6 - チォグァニン) 2 0 mM. 糖残基供与体 (ゥリ ジン、 2 ' - デォキシゥ リ ジン) 3 0 m Mおよびリ ン酸ニ水素力 リ ウム 3 0 m M を用いて実施例 1 と同様にして 5 0 °Cで 8時間反応させ„ て各種塩基供与体を塩基として保有する リ ボフラノ シル 体または 2' - デォキシリボフラノ シル体を製造した。 その結果を第 6表に示す。 Base donors (aloprinol, benzimidazole, 6-mercaptoprin, purine, 6-thioguanine) 20 mM. Sugar residue donors (peridine, 2'-dexoxylysine) 30 mM and The reaction was carried out at 50 ° C for 8 hours in the same manner as in Example 1 using lithium dihydrogenate (30 mM), and the ribofuranosyl compound or 2'-deuterine having various base donors as bases was reacted. An oxyribofuranosyl compound was produced, and the results are shown in Table 6.

第 6 表 塩 基 供 与 体 生成率 (%) 糖残基供与体 Table 6 Production rate of salt donor (%) Sugar residue donor

<対塩基比 > ァロプリ ノール ゥ リ ジン 80  <Base ratio> aloprinol peridine 80

〃 2 ' - デォキ 97  〃 2 '-Deoki 97

シゥ リ ジン ベンズイ ミ ダゾ一ル ゥ リ ジン 75  Original benzimidazolidin 75

2 ' - デォキ 86 シゥ リ ジン  2 '-Deoki 86 Series

6 - メルカプ トプリ ン ゥ リ ジン 50  6-Mercaptoprin resin 50

〃 2' - デォキ 43  〃 2 '-Deoki 43

シゥ リ ジン  Series

プリ ン ゥ リ ジン 94  Prince Resin 94

〃 2' - デォキ 65  〃 2 '-Deoki 65

シゥ リ ジン  Series

6 - チォグァニン ゥ リ ジン 9  6-Choguanine resin 9

〃 2 ' - デォキ 65  〃 2 '-Deoki 65

シゥ リ ジン  Series

実施例 4 Example 4

塩基供与体として 40 mM 1, 2, 4 - ト リァゾ一 ル - 3 - カルボキサミ ド (以下、 「 卜 リ アゾール」 とい う) 、 糖残基供与体として 40 mMのゥ リ ジン、 イ ノ シ ン、 シチジン、 アデノ シンも しく はグアノ シン、  40 mM 1,2,4-triazole-3-carboxamide (hereinafter referred to as “triazole”) as a base donor, and 40 mM pyridine and inosine as sugar residue donors , Cytidine, adenosine or guanosine,

40 mMリ ン酸ニ水素力リ ウムを含有する基質溶液 Substrate solution containing 40 mM lithium dihydrogen phosphate

(p H 6. 0) を用いて実施例 1と同様にしてリバピリ 4 一 (pH 6.0) in the same manner as in Example 1. 4 one

ンを製造した。 その結果を第 7表に示す, Manufactured. The results are shown in Table 7,

反 応 条 件 生 成 率 (%) 糖残基供与体 温 度 時 間 (対ト リ アゾール Reaction conditions Production rate (%) Sugar residue donor Temperature time (vs. triazole

(°C) (hr) 比)  (° C) (hr) ratio)

ゥ リ ジン 60 4 94. 2 イノ シン 67 48 83. 6 シチジン 50 24 92. 9 アデノ シン 67 24 72. 7 グアノ シン 67 24 98. 4 なお、 シチジン、 アデノ シンに関しては本発明のヌク レオシ ドホスホリラ一ゼは基質として認識しないため、 共存するデアミ ナーゼによりそれぞれゥリ ジン、 イノ シ ンに変換された後、 基質と して利用されていると考えら れる。  ゥ Resin 60 4 94.2 Inosine 67 48 83.6 Cytidine 50 24 92.9 Adenosine 67 24 72.7 Guanosine 67 24 98.4 The nucleoside phosphorylase of the present invention is used for cytidine and adenosine. Since zeotide does not recognize it as a substrate, it is considered that it is used as a substrate after being converted to peridine and inosine by coexisting deaminase, respectively.

実施例 5 Example 5

塩基供与体として ト リァゾール 40 mM、 糖残基供与 体としてイノ シン 60mM、 およびリ ン酸ニ水素力リウ ム 40 mMを含有する基質'溶液 (p H 6. 0) を用い、 実施例 1と同様に各反応-温度 (40〜70°C) で 24時 間反応させてリバビリ ンを製造した。 その結果を第 8表 に示す。 5 一 A substrate solution (pH 6.0) containing 40 mM triazole as a base donor, 60 mM inosine as a sugar residue donor, and 40 mM rhodium dihydrogen phosphate was used. Similarly, the reaction was carried out at each reaction-temperature (40 to 70 ° C) for 24 hours to produce ribavirin. Table 8 shows the results. 5 one

第 8 表 Table 8

反 応 温 度 40 50 60 63 65 67 70Reaction temperature 40 50 60 63 65 67 70

(°C) 生成率( !¾ ) (° C) Production rate (! ¾)

(対ト リァ 37.0 58.0 71.7 73.7 76.0 78.7 77.9 ゾール比)  (To 37.0 58.0 71.7 73.7 76.0 78.7 77.9 sol ratio)

実施例 6 Example 6

実施例 1と同様に培養して得られた培養物を遠心分離 して生菌体を得た。 次に、 生菌体 2. を 0. 1 Mト リス塩酸緩衝液 (p H 7. 0) 1. Omlに懸濁し、 別に 作製した光硬化性樹脂 (E NT— 2000 ; 関西ペイ ン ト㈱製) 8. 0 gに光重合開始剤としてべンゾイ ンェチ ルエーテル 0. 08 gを加えた樹脂液に上記菌体懸濁液 を添加し、 十分に混合した後、 透明フ ィ ルム上に流し込 み、 360 n m前後の光線をフ ィ ルム面の表裏に同時に 3分間照射して光重合物を得た。 この固定化物より菌体量と して 0. 2 gを含む部分を 取り、 細断して 40 m Mト リァゾ一ル、 40 m Mゥ リ ジ ンおよび 60 mMリ ン酸ニ水素力 リ ゥムを含む基質溶液 (p H 6. 0) 1 Omlに上記固定化物を投入し、 6◦で で 8時間攪拌しながら リバピリ ンを製造した。  The culture obtained by culturing in the same manner as in Example 1 was centrifuged to obtain viable cells. Next, the viable cell 2. was suspended in 0.1 ml of 0.1 M Tris-HCl buffer (pH 7.0), and the light-curable resin (ENT-2000; Kansai Paint II) prepared separately was suspended in Oml. The above cell suspension was added to a resin solution in which 8.0 g of benzoethyl ether as a photopolymerization initiator was added to 8.0 g, mixed well, and then poured onto a transparent film. Then, a light beam of about 360 nm was simultaneously irradiated on the front and back of the film surface for 3 minutes to obtain a photopolymer. A portion containing 0.2 g as a cell mass is taken from the immobilized product, cut into small pieces, and then cut into 40 mM triazole, 40 mM lysine and 60 mM dihydrogen phosphate. The above immobilized product was added to 1 Oml of a substrate solution (pH 6.0) containing a solution, and stirred at 6 ° for 8 hours to produce rivapirin.

前述の H P L C法で生成率を測定した結杲、 リバピリ ンの生成率は対 ト リアゾール比で 90 %であった。 さらに、 この反応を 1 0回連続して行ったが、 リバビ リ ンの生成率は 9 0 %を維持し、 酵素活性の低下は見ら れ 力、つた。 As a result of measuring the production rate by the aforementioned HPLC method, the production rate of rivapirine was 90% in terms of triazole ratio. Further, this reaction was performed 10 times continuously, but the production rate of ribavirin was maintained at 90%, and a decrease in enzyme activity was observed.

実施例 7 Example 7

実施例 1 と同様にして得られた培養物に ト リァゾール、 ゥリ ジンまたはィノ シン、 リ ン酸ニ水素力 リ ゥムをそれ ぞれ最終濃度で 4 0 mMになるように加え、 5 0 °C (ゥ リ ジンを用いた場合) または 6 5 °C (イノ シンを用いた 場合) でさらに 24時間振盪培養を行った。 培養後、 遠 心上清を H P L C法により リバビリ ンの生成率を測定し た結果、 ゥ リ ジンを用いた場合のリバピリ ンの生成率は 対ト リアゾール比で 9 1. 9 %、 イノ シンを用いた場合 は 6 5, 9 %の生成率であった。  Triazole, peridine or inosine, and dihydrogen phosphate rim were added to the culture obtained in the same manner as in Example 1 to a final concentration of 40 mM, respectively. Shaking culture was performed at 0 ° C (when using peridine) or 65 ° C (when using inosine) for an additional 24 hours. After cultivation, the centrifugal supernatant was used to measure the production rate of ribavirin by the HPLC method. As a result, the production rate of ribavirin using lysine was 91.9% in triazole ratio, and When used, the yield was 65, 9%.

実施例 8 Example 8

精製酵素の調製  Preparation of purified enzyme

バチルス · ステアロザー乇フィ ラス T H 6— 2をブ ィ ヨ ンスラ ン トよりペプ ト ン 1. 0 %、 肉汁 0. Ί %、 酵母エキス 0. 5 %、 食塩 0. 3 %を含み p H 7. 2に 調整した培地 1 Omlを入れた大型試験管に植菌し、 5 0 でで一夜培養した。 得られた培養物を同組成、 同 p Hの 培地 3 0 mlを含む 3 0 0 ml容積のフラスコに移し、 5 0 で 8時間培養し、 これを種培養と して全量を上記培地 3 S を含む 5£ 容のジャー ♦ ファーメ ンターに加え、 5 0 、 回転数 3 5 0 r.p.i, 通気量 1. O v.v.n の条 件にて 18時間培養した。 こう して得られた培養液から 遠心分離により約 30 gの湿菌体を得、 これを 1. 5ΰ の 0. 1 % トライ ト ン X— 1 00 (シダマ社製) 、 Bacillus stearotherer 乇 TH6-2 from bouillonland containing 1.0% peptone, 0.4% broth, 0.5% yeast extract, 0.3% salt, pH 7. The cells were inoculated into a large test tube containing 1 Oml of the medium adjusted to 2, and cultured at 50 overnight. The obtained culture was transferred to a 300-ml flask containing 30 ml of a medium having the same composition and the same pH, and cultured at 50 for 8 hours. 5 pound jar including ♦ Fermenter, 50, rpm 3500 rpi, air flow rate 1. O vvn Culture for 18 hours. Approximately 30 g of wet cells were obtained from the thus obtained culture solution by centrifugation, and 1.5% of 0.1% Triton X-100 (manufactured by Shidama) was obtained.

5 m M E D T Aを含む 50 m Mト リ ス -塩酸緩衝液 ( p H 7. 2) に懸濁し、 7 5 Omgのリ ゾチーム (シグ マ社製) を加え、 37 に 1時間保持した。 溶菌液を 8, 000 r. p.m.にて遠心分離し、 菌体残渣を除去した 後、 2 N塩酸を加えて p H 6. 0に調整し、 50 にて 5分間加熱処理し、 8, 000 r.p.m.にて遠心分離して 上清を粗酵素液として得た。 The suspension was suspended in 50 mM Tris-HCl buffer (pH 7.2) containing 5 mM EDTA, and 75 mg of lysozyme (manufactured by Sigma) was added, and the mixture was kept at 37 for 1 hour. The lysate was centrifuged at 8,000 rpm to remove cell debris, adjusted to pH 6.0 by adding 2N hydrochloric acid, and heat-treated at 50 for 5 minutes. And centrifuged to obtain a supernatant as a crude enzyme solution.

この粗酵素液を硫酸ァンモニゥムを用いて塩析による 分画を行い、 40%— 90%飽和で得られた蛋白沈緞を 50 mM酢酸 -酢酸ナト リ ウム緩衝液 (p H 6, 0) に 溶解させ、 大量の同緩衝液に対して一夜透折し、 得られ た内液を遠心分離して透折中に生成した沈澱を除去した t 上清を上記の酢酸緩衝液 (以下バッファー Aと記す) で 平衡化した D E A E トヨパール (東ソ一㈱製) カラムThe crude enzyme solution was fractionated by salting out using ammonium sulfate, and the protein precipitate obtained at 40% to 90% saturation was added to a 50 mM acetic acid-sodium acetate buffer (pH 6.0). lysed, overnight dialyzed against large volumes of the same buffer, the resulting inner solution centrifuged t supernatant above acetate buffer to remove the precipitate formed during dialyzed with (hereinafter buffer a and Column) equilibrated in the above)

(2. 2 X 60 cm) に通し、 吸着した蛋白を 0〜 0. 5 M食塩のリニアグラジェン ト法 (バッファ一 A使用) で 溶出し、 プリ ンヌク レオシ ドホスホリラーゼ画分と ピリ ミ ジンヌク レオシ ドホスホリラ一ゼ画分をそれぞれ回収 した。 それぞれの活性画分をバッファー Aに対して透析 後、 25ml容注射筒 (テルモ赖製) に充填した 2 Oml D E A E トョパール樹脂を用いて上記と同じ操作により - 3 S - (2.2 x 60 cm), and the adsorbed protein was eluted with a linear gradient method using 0-0.5 M salt (using buffer A), and the purine nucleoside phosphorylase fraction and pyrimidine nucleoside were eluted. Each of the dophosphorylase fractions was collected. After dialysis of each active fraction against buffer A, the same operation as above was performed using 2 Oml DEAE Toyopearl resin filled in a 25 ml syringe (manufactured by Terumo Corporation). -3 S-

カラムクロマ トグラフィ ーを行い、 それぞれの活性画分 を回収した。 次にこれらの活性画分をそれぞれバッファ 一 Aで平衡化した トヨパール HW— 5 5 S (東ソー眯製) カラム ( 2, 4 X 8 0 cm) を用いてゲル-?戸過して両醇素 をほぼ均一な精製標品として回収した。 Column chromatography was performed to collect each active fraction. Next, these active fractions were gel-filtered using a Toyopearl HW-55S (Tosoh Corporation) column (2, 4 x 80 cm) equilibrated with buffer 1A, and the components were leached. Was recovered as a substantially uniform purified sample.

両酵素の精製過程での活性画分の蛋白量、 総活性およ び精製度合を第 9表に示す。  Table 9 shows the amount of protein, the total activity, and the degree of purification of the active fractions in the purification process of both enzymes.

なお、 精製度合は、 S D S—ポリアク リルア ミ ドゲル 電気泳動法により得られた泳動パ夕一ンをデンシ トメ一 ターを用いて各バン ドの相対割合を測定する方法によつ た。 The degree of purification was determined by measuring the relative ratio of each band using a densitometer on the electrophoretic pattern obtained by SDS-polyacrylamide gel electrophoresis.

笫 9 表 笫 9 Table

Figure imgf000041_0001
Figure imgf000041_0001

Φ ¾白 Sは 608 Omgである。 »蛋白量は 377 Omgである < Φ¾white S is 608 Omg. »The amount of protein is 377 Omg <

比較例 1 Comparative Example 1

ブレビパクテリ ゥム ♦ ァセチリ カム A T 6— 7 (A T C C 3 9 3 1 1 ) およびバチルス ♦ ステアロザ 一モフィ ラス T H 6— 2の各スラ ン トより培地 (ぺプ ト ン 1 %、 肉エキス 0. 7 %、 食塩 0. 3 %、 酵母ェキ ス 0. 5 %含有、 p H 7. 2) 1 0mlを含む大型試験管 植菌し、 それぞれ 28。C (A T 6— 7の場合) および 5 0 °C (T H 6— 2の場合) で 1 8時間振盪培養した。 培養後、 それぞれの培養液を遠心分離して菌体を分離し た。 洗浄後、 同湿重量の菌体をそれぞれ 1 0 mlの脱ィォ ン水に懸濁した。  Brevipacterimu ♦ acetylicum AT 6-7 (ATCC 3931 1 1) and Bacillus ♦ stearoza monomorphus TH 6-2 The culture medium (peptone 1%, meat extract 0.7%) A large test tube containing 0.3%, 0.3% of salt, 0.5% of yeast extract, and 10 ml of pH 7.2) was inoculated, and each was 28. The cells were cultured with shaking at C (for AT 6-7) and 50 ° C (for TH 6-2) for 18 hours. After the culture, each culture was centrifuged to separate the cells. After washing, cells of the same wet weight were suspended in 10 ml of deionized water.

この菌体懸濁液それぞれに 0. 4 m M ト リアゾール、 0. 4 m Mゥリ ジンおよび 0. 4 m Mリ ン酸ニ水素力リ ゥムを含有する基質溶液 (A T 6— 7の場合は p H 7. ◦、 T H 6— 2の場合は p H 6. ひに調整) 1 0 ml を添加し、 密閉系で 4 5 °Cまたは 6 5 °Cで攪拌しながら 反応させ、 定期的にサンプリ ングして前述の H P L C法 にてリバピリ ンの生成率を測定した。  A substrate solution containing 0.4 mM triazole, 0.4 mM lysine and 0.4 mM dihydrogen phosphate was added to each of the cell suspensions (AT 6-7). If the pH is 7.◦ or TH6—2, adjust the pH to 6.) Add 10 ml and react with stirring at 45 ° C or 65 ° C in a closed system. The sample was sampled and the production rate of rivapirine was measured by the aforementioned HPLC method.

その結果を第 5図に示す。 第 5図から明らかなように、 本発明の微生物から調製した酵素調製物を用いた場合、 従来、 極めて優れた酵素'調製源であった A T 6— 7より もさらに短時間に目的化合物を製造することができ、 酵 素調製物の使用量も少量ですませることができることが 明らかとなった。 以上のように、 本発明のヌ ク レオシ ドホスホリラーゼ を含有する酵素調製物は、 比活性が高く 、 耐熱性のある ヌク レオシ ドホスホリラ一ゼを多量に含有し、 菌体単位 重量当りのヌク レオシ ドホスホリ ラーゼ活性が高いバチ ルス属の好熱菌に属する微生物群の 1種もしく は 2種以 上の微生物の菌体に由来するものであり、 このような酵 素調製物をヌク レオシ ドの製造に使用すれば、 以下の特 徴を有し、 実用性に富んだ極めて有用な方法である。 Fig. 5 shows the results. As is evident from Fig. 5, when the enzyme preparation prepared from the microorganism of the present invention was used, the target compound was produced in a shorter time than AT 6-7, which was conventionally a very excellent source of enzyme preparation. It was clarified that the enzyme preparation could be used in a small amount. As described above, the enzyme preparation containing nucleoside phosphorylase of the present invention contains a large amount of nucleoside phosphorylase having high specific activity and heat resistance, and contains a large amount of nucleoside phosphorylase per unit weight of bacterial cell. It is derived from one or two or more microorganisms belonging to the thermophilic bacterium belonging to the genus Bacillus, which has a high enzyme activity.These enzyme preparations are used for the production of nucleosides. It is a very useful and practical method that has the following features.

① 比活性の高いヌク レオシ ドホスホリ ラーゼを多量 に含有しており、 ヌク レオシ ドの製造に使用した場合に は少量の酵素量で収率よく ヌ ク レオシ ドを製造すること ができる。  (1) It contains a large amount of nucleoside phosphorylase with high specific activity. When used for nucleoside production, nucleoside can be produced with high yield with a small amount of enzyme.

② 至適温度および安定温度範囲が比較的高温域にあ るヌク レオシ ドホスホリ ラーゼを含有している。 このた め、 反応を高温で行う ことができ、 雑菌の汚染による酵 素の失活、 反応生成物の分解等を抑制することができる。 ② Contains nucleoside phosphorylase whose optimum and stable temperature ranges are relatively high. For this reason, the reaction can be performed at a high temperature, and the inactivation of the enzyme due to contamination of various bacteria and the decomposition of the reaction product can be suppressed.

③ ヌ ク レオシ ドホスホリラーゼと してプリ ンヌク レ オシ ドホスホリラ一ゼとピリ ミ ジンヌ ク レオシ ドホスホ リラーゼの両方の酵素を含有する調製物を得ることもで き、 このような調製物をヌク レオシ ド製造に使用すれば、 例えば下記の反応式に示されたごとく、 2つの酵素が共 同して作用するため、 1種類のヌ ク レオシ ドホスホリ ラ ーゼしか含有しない酵素調製物と比較して 2倍以上の速 度でヌク レオシ ドを製造することができる。 (プリ ンヌク レオシ ③ It is also possible to obtain a preparation containing both of the enzymes, purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, as nucleoside phosphorylases. For example, as shown in the following reaction formula, the two enzymes work together, and are twice as large as an enzyme preparation containing only one type of nucleoside phosphorylase. Nucleosides can be produced at the above speed. (Prin Nuku Reoshi

ドホスホリ ラーゼ)  Dophosphorylase)

1  1

糖残基供与体 -> 糖残基供与体 Sugar residue donor-> Sugar residue donor

(プリ ンヌ ク の糖部分  (Sugar portion of prin nu

レオシ ド)  Leoside)

プリ ン塩基  Purine base

(ピリ ミ ジンヌク レオ (Pirimi Jinnuk Leo

シ ドホスホリラ一ゼ) Side phosphorylase)

1  1

- ピリ ミ ジ ンヌ ク レオ シ ド 个 - -:リ ミ ジン塩基 また、 本発明の微生物は比較的高温で生育して生育速 度も速く、 培養して得られた菌体には前述のようなヌク レオシ ドの製造に適した酵素を多量に含有しているため ヌク レオシ ド製造に使用するための酵素調製物またはそ の調製源と して極めて有用である。  -Pyrimidine nucleoside individual--: Limidine base The microorganism of the present invention grows at a relatively high temperature and grows at a high growth rate. It is extremely useful as an enzyme preparation or a preparation source for use in nucleoside production because it contains a large amount of an enzyme suitable for the production of a nucleoside.

さらに、 本発明の酵素調製物として微生物の培養物を 用いれば菌体の自己消化を防止することもできる。  Furthermore, when a culture of a microorganism is used as the enzyme preparation of the present invention, autolysis of the cells can be prevented.

また、 上記本発明の微生物から得られるヌク レオシ ド ホスホリラーゼは、 高い比活性を有し、 かつ比較的高温 域に至適温度と安定温度範囲を有するという特徴から公 知のヌク レオシ ドホスホリラーゼとは明確に区別される ものである。 また、 このような酵素をヌ ク レオシ ドの製 造に使用すれば、 上述の①および②の効果を有する。 ま た、 本発明のプリ ンヌク レオシ ドホスホリラ一ゼとピリ ミ ジンヌ ク レオシ ドホスホリ ラ一ゼの両方の酵素を使用 すれば、 当然上述の③の効果を奏する。 In addition, the nucleoside phosphorylase obtained from the microorganism of the present invention has a high specific activity, and has an optimum temperature and a stable temperature range in a relatively high temperature range. They are clearly distinguished. Further, when such an enzyme is used for producing a nucleotide, the above-mentioned effects (1) and (2) are obtained. In addition, the purine nucleoside phosphorylase of the present invention is If both enzymes are used, naturally the above-mentioned effect (3) will be achieved.

産業上の利用可能性  Industrial applicability

本発明のヌ ク レオシ ドの製造法は、 バチルス属の好熱 菌に属す比活性が高く、 耐熱性のあるヌク レオシ ドホス ホリラ一ゼを大量含有し、 菌体単位重量当りのヌク レオ シ ドホスホリ ラーゼ活性の高い微生物群の微生物菌体に 由来する酵素調製物をヌク レオシ ド製造のための酵素源 として使用しており、 わずかな酵素量で収率よく 目的と するヌク レオシ ドを製造することができ、 極めて実用的 な方法である。  The method for producing a nucleoside of the present invention comprises a large amount of heat-resistant nucleoside phosphorylase belonging to a thermophilic bacterium belonging to the genus Bacillus, which contains a large amount of nucleoside phosphorylase. Enzyme preparations derived from microbial cells of microorganisms with high enzyme activity are used as an enzyme source for the production of nucleosides, and the target nucleosides can be produced with a small amount of enzyme in high yield. This is a very practical method.

Claims

請 求 の 範 囲 The scope of the claims 1 . 塩基供与体、 糖残基供与体およびリ ン酸供与体 をヌク レオシ 卜ホスホリラーゼ (nuc l eosi de phosphory - se) を含有する酵素調製物を用いて反応させて塩基供 与体の塩基部分と糖残基供与体の糖部分との間で N - グ リ コシ ド結合を形成させてヌク レオシ ドを製造する方法 において、 ヌク レオシ ドホスホリラーゼを含有する酵素 調製物として、 バチルス属の好熱菌に属し、 菌体単位重 量当りのヌク レオシ ドホスホリラーゼ活性が高い微生物 群の 1種または 2種以上の微生物の菌体に由来するもの を用いることを特徴とするヌクレオシ ドの製造法。 1. A base donor, a sugar residue donor, and a phosphate donor are reacted using an enzyme preparation containing nucleoside phosphorylase (se), and the base moiety of the base donor is reacted. A method for producing a nucleoside by forming an N-glycosidic bond between a nucleoside phosphorylase and a saccharide moiety of a bacterium belonging to the genus Bacillus. A method for producing a nucleoside, comprising using a microorganism derived from one or more microorganisms of a microorganism group belonging to a microorganism and having a high nucleoside phosphorylase activity per unit weight of the microorganism. 2 . 酵素調製物と して、 菌体単位重量当りのヌク レ ォシ ドホスホリラーゼ活性が以下の条件を少なく とも 1 つ満足する菌体由来のものを使用する、 請求項 1に記載 のヌ ク レオシ ドの製造法。  2. The enzyme preparation according to claim 1, wherein the enzyme preparation is a cell derived from a cell having a nucleotide phosphorylase activity per unit weight of the cell that satisfies at least one of the following conditions. Reoside manufacturing method. ① プリ ンヌク レオシ ドホスホリラーゼ活性  ① Prin nucleoside phosphorylase activity 1 0 U / g湿菌体以上  10 U / g wet cells or more ② ピリ ミ ジンヌク レオシ ドホスホリラーゼ活性  ② Pyrimidine nucleoside phosphorylase activity 1 O U / g湿菌体以上  1 O U / g wet cells or more 3 . 酵素調製物として、 菌体単位重量当りのヌク レ ォシ ドホスホリラーゼ活性が以下の条件を同時に满足す る菌体由来のものを使用する、 請求項 1に記載のヌク レ ォシ ドの製造法。 ① プリ ンヌ ク レオシ ドホスホリ ラ一ゼ活性 3. The enzyme preparation according to claim 1, wherein the enzyme preparation has a nucleoside phosphorylase activity per unit weight of the bacterium that satisfies the following conditions simultaneously. Manufacturing method. ① Prin nucleoside phosphorylase activity 10 UZg湿菌体以上  10 UZg wet cells or more ② ピリ ミ ジンヌ ク レオシ ドホスホ リ ラ一ゼ活性  ② Pyrimidine nucleoside phosphorylase activity 10 UZg湿菌体以上  10 UZg wet cells or more 4. 酵素調製物と して、 バチルス属の中等度好熱菌 の菌体由来のものを使用する、 請求項 1〜3のいずれか —項に記載のヌ ク レオシ ドの製造法。  4. The method for producing a nucleotide according to any one of claims 1 to 3, wherein an enzyme preparation derived from a medium thermophilic bacterium of the genus Bacillus is used. 5. 酵素調製物として、 バチルス ♦ ステアロザーモ フイ ラス菌体由来のものを使用する、 請求項 1〜3のい ずれか一項に記載のヌ ク レオシ ドの製造法。  5. The method for producing a nucleotide according to any one of claims 1 to 3, wherein an enzyme preparation derived from Bacillus ♦ stearothermophilus cells is used. 6. 酵素調製物の形態が、 微生物の培養物、 生菌体 または菌体処理物である、 請求項 1〜 3のいずれか一項 に記載のヌ ク レオシ ドの製造法。  6. The method for producing a nucleoside according to any one of claims 1 to 3, wherein the form of the enzyme preparation is a culture, a viable cell, or a processed cell of a microorganism. 7. 菌体単位重量当りのヌ ク レオシ ドホスホリ ラ一 ゼ活性が以下の条件を少なく とも 1つ満足する微生物。 7. A microorganism having a nucleoside phosphorylase activity per unit weight of the cell that satisfies at least one of the following conditions. ① プリ ンヌ ク レオシ ドホスホ リ ラーゼ活性 ① Prin nucleoside phosphorylase activity 10 UZ g湿菌体以上  10 UZ g or more wet cells ② ピリ ミ ジンヌ ク レオシ ドホスホ リ ラーゼ活性  ② Pyrimidine nucleoside phosphorylase activity 10 U/g湿菌体以上  10 U / g wet cells or more 8. 菌体単位重量当りのヌ ク レオシ ドホスホ リ ラー ゼ活性が以下の条件を同時に満足する微生物。  8. A microorganism whose nucleoside phosphorylase activity per unit cell weight satisfies the following conditions at the same time. ① プリ ンヌ ク レオシ ドホスホリ ラーゼ活性  ① Prin nucleoside phosphorylase activity 10 UZ g湿菌体以上  10 UZ g or more wet cells ② ピリ ミ ジンヌ ク レオシ ドホスホ リ ラーゼ活性 1 0 UZ g湿菌体以上 ② Pyrimidine nucleoside phosphorylase activity More than 10 UZ g wet cells 9. 微生物がバチルス属の好熱菌に属するものであ る、 請求項 7または 8に記載の微生物。  9. The microorganism according to claim 7 or 8, wherein the microorganism belongs to a thermophilic bacterium of the genus Bacillus. 1 0. 微生物がバチルス属の中等度好熱菌に属する ものである、 請求項 7または 8に記載の微生物。  10. The microorganism according to claim 7, wherein the microorganism belongs to a medium thermophilic bacterium of the genus Bacillus. 1 1. 微生物がバチルス , ステアロザー乇フィ ラス に属するものである、 請求項 7または 8に記載の微生物, 1 1. The microorganism according to claim 7 or 8, wherein the microorganism belongs to Bacillus, Stearorisa filasus. 1 2. 以下の性質を有するプリ ンヌク レオシ ドホス ホリラーゼ。 1 2. Purine nucleoside phosphorylase having the following properties. ① 温度安定性 : 60 、 1 5分間の加熱処理におい ても安定  ① Temperature stability: Stable even when heated for 60 to 15 minutes ② 比 活 性 : 80 %の酵素の精製度合で 400  ② Specific activity: 400 at 80% enzyme purification (U/mg) 以上  (U / mg) or more 1 3. 以下の性質を有するピリ ミ ジンヌク レオシ ド ホスホリ ラーゼ。  1 3. A pyrimidine nucleoside phosphorylase having the following properties. ① 温度安定性: 60 、 1 5分間の加熱処理におい ても安定  ① Temperature stability: Stable even after heating for 60 or 15 minutes ② 比 活 性 : 80%の酵素の精製度合で 250  ② Specific activity: 250% with 80% enzyme purification (U/mg) 以上  (U / mg) or more
PCT/JP1990/000240 1989-02-28 1990-02-27 Production of nucleoside Ceased WO1990010080A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1019900702343A KR970010134B1 (en) 1989-02-28 1990-02-27 Production of nucloside
EP90903422A EP0411158B1 (en) 1989-02-28 1990-02-27 Process for producing nucleosides by using phosphorylases obtainable from Bacillus stearothermophilus
CA002028119A CA2028119C (en) 1989-02-28 1990-02-27 Process for producing nucleosides
DE69027154T DE69027154T2 (en) 1989-02-28 1990-02-27 Process for the preparation of nucleosides by using phosphorylases obtainable from Bacillus stearothermophilus
US08/319,574 US5506122A (en) 1989-02-28 1994-10-07 Process for producing nucleosides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1/48785 1989-02-28
JP4878589 1989-02-28
JP1/203556 1989-08-04
JP20355689 1989-08-04

Publications (1)

Publication Number Publication Date
WO1990010080A1 true WO1990010080A1 (en) 1990-09-07

Family

ID=26389109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1990/000240 Ceased WO1990010080A1 (en) 1989-02-28 1990-02-27 Production of nucleoside

Country Status (11)

Country Link
US (3) US5258301A (en)
EP (1) EP0411158B1 (en)
JP (1) JP2795748B2 (en)
KR (1) KR970010134B1 (en)
AT (1) ATE138689T1 (en)
AU (1) AU631607B2 (en)
CA (1) CA2028119C (en)
DE (1) DE69027154T2 (en)
DK (1) DK0411158T3 (en)
ES (1) ES2089010T3 (en)
WO (1) WO1990010080A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2795748B2 (en) * 1989-02-28 1998-09-10 ヤマサ醤油株式会社 Method for producing nucleoside
RS49561B (en) * 1993-12-14 2007-04-10 Galenika A.D., Procedure for the enzymatic synthesis of triazolo nucleosides using thermophilic bacteria
US5547857A (en) * 1994-04-18 1996-08-20 Ajinomoto Co., Inc. Process for producing 5-methyluridine and purification by sedimentation velocity
WO1998017781A1 (en) * 1996-10-21 1998-04-30 University Of Iowa Research Foundation Efficient synthesis of nucleosides
JP3864357B2 (en) * 1997-08-04 2006-12-27 有機合成薬品工業株式会社 Method for producing purine nucleoside compound
JP3799784B2 (en) * 1997-11-14 2006-07-19 味の素株式会社 Process for producing 2,6-diaminopurine-2'-deoxyriboside and 2'-deoxyguanosine
JP2003507071A (en) 1999-08-20 2003-02-25 ロシュ ダイアグノスティックス ゲーエムベーハー Enzymatic synthesis of deoxyribonucleosides
RU2179188C2 (en) * 2000-03-03 2002-02-10 Институт биоорганической химии им. М.М. Шемякина и Ю.А. Овчинникова РАН Method of producing recombinant purine nucleoside phosphory-lase, recombinant plasmid dna perpupho1 and strain escherichia coli bl21(de3)perpuho1 for its realization
JP4066121B2 (en) 2000-03-27 2008-03-26 有機合成薬品工業株式会社 Process for producing guanosine and its intermediate
US6858721B2 (en) * 2001-05-01 2005-02-22 Mitsui Chemicals, Inc. Method for producing cytosine nucleoside compounds
KR101818561B1 (en) * 2016-03-21 2018-01-15 에스티팜 주식회사 Method for Preparing 3'-Amino-2',3'-dideoxyadenosine by Using Nucleoside Phosphorylase Derived from Bacillus
KR101818564B1 (en) * 2016-03-21 2018-01-15 에스티팜 주식회사 Methods for Preparing 3'-amino-2',3'-dideoxyguanosine by Using Nucleoside Phosphorylases Derived from Bacillus and Adenosine Deaminase Derived from Lactococcus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01320995A (en) * 1988-06-22 1989-12-27 Japan Tobacco Inc Production of nucleoside compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56148289A (en) * 1980-04-18 1981-11-17 Unitika Ltd Preparation of heat-resistant polynucleotide phosphorylase
US4331762A (en) * 1980-04-18 1982-05-25 Unitika Ltd. Bacillus stearothermophilus strain UK 788 and process for producing a useful enzyme
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
JPS58170493A (en) * 1982-04-01 1983-10-07 Yamasa Shoyu Co Ltd Preparation of 3'-deoxyguanosine
US4614719A (en) * 1982-04-30 1986-09-30 Yamasa Shoyu Kabushiki Kaisha Process for producing ribavirin
JP2795748B2 (en) * 1989-02-28 1998-09-10 ヤマサ醤油株式会社 Method for producing nucleoside
JP3080771B2 (en) * 1992-04-17 2000-08-28 ユニチカ株式会社 Method for producing dinucleoside polyphosphate or derivative thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01320995A (en) * 1988-06-22 1989-12-27 Japan Tobacco Inc Production of nucleoside compound

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Agricultural and Biological Chemistry Vol. 53, No. 12, (1989), NOBUAKI HORI et al. "Purification and Characterization of Second Thermostable Purine Nucleoside Phosphorylase in Bacillus Stearothermophilus JTS859" p. 3219-3224 *
Agricultural and Biological Chemistry, Vol. 53, No. 1, (1989), NOBUAKI HORI et al. "Synthesis of 5-Methyluridine by a Thermophile, Balcillus Stearothermophilus JTS859" p. 197-202 *
Agricultural and Biological Chemistry, Vol. 53, No. 8, (1989), NOBUAKI HORI et al. "Purification and Characterization of Thermostable Purine Nucleoside Phosphorylase of Bacillus Stearothermophilus JTS859" p. 2205-2210 *

Also Published As

Publication number Publication date
JP2795748B2 (en) 1998-09-10
US5384251A (en) 1995-01-24
ATE138689T1 (en) 1996-06-15
EP0411158A1 (en) 1991-02-06
KR970010134B1 (en) 1997-06-21
AU5108090A (en) 1990-09-26
CA2028119A1 (en) 1990-08-29
AU631607B2 (en) 1992-12-03
DE69027154T2 (en) 1996-10-24
US5506122A (en) 1996-04-09
DE69027154D1 (en) 1996-07-04
CA2028119C (en) 2000-05-16
ES2089010T3 (en) 1996-10-01
EP0411158A4 (en) 1992-03-11
KR920700290A (en) 1992-02-19
DK0411158T3 (en) 1996-06-17
US5258301A (en) 1993-11-02
EP0411158B1 (en) 1996-05-29

Similar Documents

Publication Publication Date Title
WO1990010080A1 (en) Production of nucleoside
JPWO1990010080A1 (en) Nucleoside production method
JP3764755B2 (en) &#34;Production Method of Adenosine 5&#39;-Triphosphate and Its Application&#34;
JPS58170493A (en) Preparation of 3&#39;-deoxyguanosine
JP3026857B2 (en) Novel pullulanase and method for producing the same
JP3635133B2 (en) Trehalose phosphorylase and preparation method thereof
DK143947B (en) GLUCOSE ISOMERIZING ENZYM AND PROCEDURES FOR PREPARING IT, AND PROCESS FOR THE CONVERSION OF GLUCOSE TO FRUCTOSE
JP3062409B2 (en) Novel β-galactoside-α2,6-sialyltransferase and method for producing the same
JP4058663B2 (en) Method for producing ribose 1-phosphates and nucleoside compounds
JP4058667B2 (en) Method for producing 2&#39;-deoxynucleoside compound
JP2572890B2 (en) Method for producing nucleoside compound
JPH08173182A (en) Production of saccharides containing sialic acid
JPH0515368A (en) New pullulanase and production thereof
JPWO1999011810A1 (en) Method for producing uridine diphosphate-N-acetylglucosamine
JP2544480B2 (en) Purine nucleoside phosphorylase and method for producing the same
JPH05137572A (en) Thermostable adenosine-5&#39;-triphosphate sulfurylase and its production
JPH05236954A (en) Heat-resistant adenosine-5&#39;-phosphosulfate kinase and its production
JPH0458881A (en) Arthrobacter sp-k-1
JPS59179094A (en) Production of triazol-deoxyribonucleoside
JPH03198790A (en) Production of 5-ethynyl-1-beta-d-ribofuranosylimidazole-4-carboxamide
JPS58190396A (en) Preparation of ribavirin
JPS60120981A (en) Novel strain of brevibacterium acetylicum
JPS6253149B2 (en)
JPH0797986B2 (en) Heat-resistant acetic acid kinase and method for producing the same
JPH05137571A (en) Thermostable adenosine-5&#39;-phosphosulfate kinase and its production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 2028119

Country of ref document: CA

Ref document number: 1990903422

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1990903422

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1990903422

Country of ref document: EP